Cholecystitis

K11_CHOLECYST

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K81 Hospital discharge: ICD-9 — 575[0-1] Hospital discharge: ICD-8 — 5750[0-3] Cause of death: ICD-10 — K81 Cause of death: ICD-9 — 575[0-1] Cause of death: ICD-8 — 5750[0-3] 2 out of 7 registries used, show all original rules.	6055
4. Check minimum number of events None	6055
5. Include endpoints None	6055
6. Filter based on genotype QC (FinnGen only)	6055

Control definitions (FinnGen only)

Control exclude: K11_GALLBILPANC

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K80-K87
Name in latin: Cholecystitis

NAME	K11_CHOLECYST
CONTROL_EXCLUDE	K11_GALLBILPANC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K81
HD_ICD_9	575[0-1]
HD_ICD_8	5750[0-3]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K81
COD_ICD_9	575[0-1]
COD_ICD_8	5750[0-3]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cholecystitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	62108	32346	29007
Only index persons	45496	24241	21255
Unadjusted period prevalence (%)
Whole population	0.87	0.93	0.81
Only index persons	0.85	0.89	0.81
Median age at first event (years)
Whole population	65.72	64.16	67.45
Only index persons	63.44	60.65	66.62

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6055	2806	3249
Unadjusted period prevalence (%)	1.21	0.96	1.43
Median age at first event (years)	61.75	54.95	67.62

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5435: Matched controls
54340

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

3924.2

323.0

1510

R10.1

ICD-10 Finland

Pain localized to upper abdomen

4.9

323.0

1382

3546

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

912.0

323.0

2063

K81.0

ICD-10 Finland

Acute cholecystitis

7093.8

323.0

2732

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

8.0

323.0

1079

1631

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

+∞

323.0

407

K81.9

ICD-10 Finland

Cholecystitis, unspecified

10846.4

323.0

1580

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.4

323.0

2450

10453

UJK02

NOMESCO Finland

ERCP

70.8

323.0

473

K81.1

ICD-10 Finland

Chronic cholecystitis

+∞

323.0

404

JKA20

NOMESCO Finland

Cholecystectomy

116.2

323.0

820

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

44.7

323.0

417

101

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

290.8

323.0

1289

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

747.8

323.0

479

57500

ICD-8 Finland

Cholecystitis and cholangitis, without mention of calculus, Cholecystitis acuta

+∞

323.0

485

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.5

292.3

1204

3257

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

897.2

263.7

257

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

105.4

255.9

280

K83.0

ICD-10 Finland

Cholangitis

1275.5

251.8

244

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

77.8

234.2

266

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.3

226.8

943

2516

K80.4

ICD-10 Finland

Calculus of bile duct with cholecystitis

1133.7

224.4

218

5750A

ICD-9 Finland

Other disorders of gallbladder, Acute cholecystitis

+∞

203.4

194

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

1905.6

201.1

194

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

81.5

194.1

219

JN3AD

NOMESCO Finland

Abdominal CT examination

4.7

189.4

704

1660

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

+∞

178.1

170

K81.8

ICD-10 Finland

Other cholecystitis

1732.7

167.5

162

K80.8

ICD-10 Finland

Other cholelithiasis

56.7

152.1

181

K83.1

ICD-10 Finland

Obstruction of bile duct

1517.5

149.6

145

57501

ICD-8 Finland

Cholecystitis and cholangitis, without mention of calculus, Cholecystitis chronica

+∞

147.5

141

J01DB01

ATC

cefalexin; oral

2.3

136.8

4310

34200

K85

ICD-10 Finland

Acute pancreatitis

90.7

134.8

150

J01MA12

ATC

levofloxacin; systemic

2.5

133.4

1306

6167

TJK01

NOMESCO Finland

Laparoscopic cholangiography

669.1

133.2

131

TJK00

NOMESCO Finland

Intraoperative cholangiography

324.4

126.9

128

K85.1

ICD-10 Finland

Biliary acute pancreatitis

+∞

120.2

115

6663

FHL

Cholecystectomy and cholangiography

292.7

112.4

114

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

111.8

1703

9758

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

50.3

105.6

128

A02BC02

ATC

pantoprazole; systemic

1.9

105.2

3462

26199

N02BE01

ATC

paracetamol; systemic, rectal

2.2

105.2

4545

38167

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

100.3

1482

8307

5751A

ICD-9 Finland

Other disorders of gallbladder, Other cholecystitis

+∞

99.2

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

37.1

98.6

127

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

+∞

98.2

D98

ICPC

Cholecystitis/cholelithiasis

74.9

96.6

110

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

92.2

2453

16941

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

88.7

1488

8694

P01AB01

ATC

metronidazole; oral, rectal

1.8

86.0

1969

12838

C03CA01

ATC

furosemide; systemic

1.8

85.5

2038

13462

N02AX02

ATC

tramadol; systemic, rectal

1.8

85.5

2300

15806

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.4

82.3

777

3501

57409

ICD-8 Finland

Cholelithiasis, Unspecified

+∞

81.4

K86.1

ICD-10 Finland

Other chronic pancreatitis

779.2

78.5

R10.0

ICD-10 Finland

Acute abdomen

5.4

78.5

249

482

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

+∞

77.2

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

76.4

1620

10195

J01MA02

ATC

ciprofloxacin; systemic

1.7

76.3

2184

15132

103

Kela drug reimbursment

Diabetes, insulin-treated

1.8

75.2

1605

10107

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

372.3

73.9

JAH01

NOMESCO Finland

Laparoscopy

4.2

72.3

288

707

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

72.0

1182

6762

57401

ICD-8 Finland

Cholelithiasis, Cum cholecystitide chronica

+∞

72.0

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

111.5

71.0

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

70.1

948

5017

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.9

69.5

1311

7876

R50.9

ICD-10 Finland

Fever, unspecified

2.2

67.8

810

4056

T90

ICPC

Diabetes non-insulin dependent

1.9

67.2

1280

7699

JK1AT

NOMESCO Finland

Cathetrisation of bile cyst with radiological guidance

+∞

66.8

A09AA02

ATC

multienzymes (lipase, protease etc.)

10.8

66.1

130

123

6662

FHL

Cholecystectomy

55.7

64.9

K85.8

ICD-10 Finland

Other acute pancreatitis

+∞

64.7

A10BA02

ATC

metformin; oral

1.7

64.4

1598

10456

K81

ICD-10 Finland

Cholecystitis

166.9

63.1

D02

ICPC

Abdominal pain epigastric

3.4

61.9

325

1008

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.3

60.9

333

1065

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

59.1

1022

5903

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.7

59.1

277

785

SPAT1263

SPAT

Sampling

1.6

58.6

2122

15356

57400

ICD-8 Finland

Cholelithiasis, Cum cholecystitide acuta

+∞

58.4

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

5.7

56.7

168

300

JK2AT

NOMESCO Finland

Puncture of bile cyst with ultrasound guidance

+∞

56.3

57503

ICD-8 Finland

Cholecystitis and cholangitis, without mention of calculus, Cholecystitis alia sive NUD

+∞

56.3

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

56.1

841

4598

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.8

55.7

253

698

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

55.7

813

4395

B01AB05

ATC

enoxaparin; parenteral

1.7

55.4

1582

10686

A02BC05

ATC

esomeprazole; systemic

1.6

55.2

1962

14068

5742A

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder without mention of cholecystitis[CHOLECYSTOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]

+∞

54.2

SPAT1262

SPAT

Handing over of treatment supplies

1.8

53.5

1011

5997

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

7.6

52.9

127

170

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

115.2

52.9

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

52.3

3166

25728

N02AA05

ATC

oxycodone; systemic

1.9

52.1

876

4984

WX402

NOMESCO Finland

General anaesthesia

2.0

51.6

761

4120

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

7.1

50.3

126

180

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.2

47.7

266

861

K80

ICD-10 Finland

Cholelithiasis

13.6

47.4

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

47.3

537

2602

E66.01

ICD-10 Finland

Obesity due to excess calories

2.6

46.8

353

1389

N03AX16

ATC

pregabalin; oral

1.7

45.9

1139

7320

57408

ICD-8 Finland

Cholelithiasis, Alia definita

+∞

45.9

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

44.9

928

5636

J01DA01

ATC

[U] cefalexin; systemic

1.5

43.7

3099

25573

A41.9

ICD-10 Finland

Sepsis, unspecified

3.0

43.4

271

946

R06.0

ICD-10 Finland

Dyspnoea

1.6

42.5

1276

8621

D01

ICPC

Abdominal pain/cramps general

2.2

42.3

468

2240

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

14.7

42.0

A10AE04

ATC

insulin glargine; parenteral

2.1

41.5

510

2554

E66.8

ICD-10 Finland

Other obesity

3.1

41.1

243

820

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

41.0

740

4286

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

40.9

1350

9330

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

10.4

40.8

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

40.7

564

2964

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

+∞

40.7

WX110

NOMESCO Finland

Local anesthesy

1.5

40.3

3020

25006

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

42.0

40.3

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.0

40.0

558

2938

K86.2

ICD-10 Finland

Cyst of pancreas

206.4

39.9

UJF32

NOMESCO Finland

Coloscopy

1.6

39.8

1294

8895

SPAT1254

SPAT

Administration of medicine

1.8

39.6

808

4867

H02AB06

ATC

prednisolone; systemic

1.5

39.3

2292

17993

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

201.4

38.9

A02BC01

ATC

omeprazole; systemic

1.6

38.7

1427

10112

K86.3

ICD-10 Finland

Pseudocyst of pancreas

+∞

38.6

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

38.3

1434

10188

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

37.7

2224

17445

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

37.6

907

5744

5740A

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder with acute cholecystitis[CHOLECYSTOLITHIASIS CUM CHOLECYSTITIDE AC,SINE OBST]

+∞

37.5

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

37.1

901

5712

K82.2

ICD-10 Finland

Perforation of gallbladder

+∞

36.5

JKB20

NOMESCO Finland

Intraoperative cholangioscopy

+∞

36.5

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

36.3

1483

10730

A06AD11

ATC

lactulose; oral

1.7

35.7

883

5621

C07AB07

ATC

bisoprolol; oral

1.4

35.3

2553

20747

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

34.9

525

2840

JKB00

NOMESCO Finland

Incision of bile duct

181.1

34.8

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.2

34.7

389

1869

N03AX12

ATC

gabapentin; oral

1.8

34.4

714

4310

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

33.8

881

5680

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

33.4

732

4490

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

33.4

919

6015

5741A

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder with other cholecystitis[CHOLECYSTOLITHIASIS CUM CHOLECYSTITIDE CHR,SINE OBS]

+∞

33.4

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

9.8

32.9

L28

ICPC

Limited function/disability (L)

1.7

32.9

856

5516

A05AA02

ATC

ursodeoxycholic acid; oral

6.6

32.3

128

B01AA03

ATC

warfarin; systemic

1.5

31.8

1267

9066

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

31.7

884

5797

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

31.6

2071

16399

A02BA02

ATC

ranitidine; systemic

1.6

31.5

1035

7072

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

53.2

31.3

JK3AT

NOMESCO Finland

Catherisation of bile duct with ultrasound guidance

+∞

31.3

A02BC03

ATC

lansoprazole; oral

1.5

31.2

1419

10441

R53

ICD-10 Finland

Malaise and fatigue

1.6

31.1

1014

6915

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.3

31.0

313

1432

AA1AD

NOMESCO Finland

CT of head and brain

1.5

30.6

1231

8813

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.2

30.4

168

542

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

30.3

480

2640

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

30.3

807

5220

B03BA03

ATC

hydroxocobalamin; parenteral

2.1

30.2

363

1795

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

30.0

826

5392

R11

ICD-10 Finland

Nausea and vomiting

2.0

29.9

387

1971

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

29.8

399

2059

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

29.6

1780

13821

G47.3

ICD-10 Finland

Sleep apnoea

1.6

29.5

899

6019

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

29.3

257

1097

57502

ICD-8 Finland

Cholecystitis and cholangitis, without mention of calculus, Empyema vesicae fellae

+∞

29.2

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.0

29.1

422

2246

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

29.0

726

4614

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

28.9

1342

9888

R03AC02

ATC

salbutamol; inhalant

1.4

28.8

2323

18997

C10AC01

ATC

colestyramine; oral

3.6

28.7

132

370

WX704

NOMESCO Finland

Intubation

2.1

28.6

332

1616

M04AA01

ATC

allopurinol; systemic

1.6

28.6

757

4882

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

28.5

1509

11412

N05CF01

ATC

zopiclone; oral

1.4

28.3

1660

12798

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

3.7

28.2

127

350

JK3MB

NOMESCO Finland

Postoperative cholangiography

+∞

28.1

5770A

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA NONHAEMORRHAGICA]

+∞

28.1

J01AA02

ATC

doxycycline; systemic

1.4

28.1

3800

33875

A46

ICD-10 Finland

Erysipelas

1.6

27.7

731

4708

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

27.6

757

4927

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

27.5

700

4464

JLB28

NOMESCO Finland

Endoscopic internal drainage of pancreatic duct

+∞

27.1

205

Kela drug reimbursment

Chronic hypertension

1.4

27.0

1625

12571

JAH00

NOMESCO Finland

Laparotomy

3.0

26.9

163

561

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

26.7

791

5244

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

272.3

26.7

K30

ICD-10 Finland

Functional dyspepsia

1.9

26.6

441

2464

A10BH01

ATC

sitagliptin; oral

1.8

26.6

478

2743

A28

ICPC

Limited function/disability NOS

1.6

26.5

845

5707

SPAT1216

SPAT

Assessment of functional ability

1.6

26.4

806

5387

SPAT1255

SPAT

Intravenous administration of medicine

2.0

26.4

344

1759

E66.00

ICD-10 Finland

Metabolic syndrome

2.3

26.1

243

1070

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.3

26.1

235

57709

ICD-8 Finland

Diseases of pancreas, Pancreatitis NUD

+∞

26.1

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

+∞

26.1

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

26.0

757

5000

M79.6

ICD-10 Finland

Pain in limb

1.4

26.0

1529

11754

WX882

NOMESCO Finland

High dependency care

2.9

25.3

158

556

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

25.1

25.2

E66.9

ICD-10 Finland

Obesity, unspecified

2.9

25.2

158

557

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

24.8

205

849

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

24.6

936

6581

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

24.6

1810

14450

WX002

NOMESCO Finland

Sedation and analgesia

1.5

24.5

912

6374

J01CA04

ATC

amoxicillin; systemic

1.4

24.3

3669

32811

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

24.2

1323

10007

A41.8

ICD-10 Finland

Other specified sepsis

3.5

24.1

114

329

UJK12

NOMESCO Finland

Peroral cholangioscopy

67.7

23.8

N06AX11

ATC

mirtazapine; oral

1.4

23.8

1375

10507

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

23.6

1034

7479

S18

ICPC

Laceration/cut

1.4

23.6

1909

15454

J01FF01

ATC

clindamycin; systemic

1.4

23.5

1184

8809

R60.0

ICD-10 Finland

Localized oedema

1.7

23.5

533

3287

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

23.2

1134

8380

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.2

23.0

240

1115

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

23.0

361

1978

5770D

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA NONHAEMORHAGICA]

+∞

22.9

SPAT1229

SPAT

Assessment of need for aid

1.8

22.9

423

2447

C01DA14

ATC

isosorbide mononitrate; oral

1.5

22.8

995

7187

SPAT1153

SPAT

Removal of sutures

1.4

22.8

1464

11383

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.8

22.7

262

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

22.6

681

4524

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.5

22.5

105

300

M54.5

ICD-10 Finland

Low back pain

1.4

22.3

1321

10119

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

22.1

624

4078

A10AE05

ATC

insulin detemir; parenteral

2.1

22.1

266

1317

57403

ICD-8 Finland

Cholelithiasis, Choledocholithiasis

+∞

21.9

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

21.8

668

4454

J01FA06

ATC

roxithromycin; oral

1.4

21.8

1810

14663

SPAT1301

SPAT

No procedures

1.4

21.6

1478

11591

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

43.5

21.4

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

21.3

554

3543

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.4

21.3

187

799

C03DA01

ATC

spironolactone; oral

1.6

21.1

566

3645

WX004

NOMESCO Finland

Patient-controlled sedation

10.9

21.1

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

20.8

1885

15449

K29.7

ICD-10 Finland

Gastritis, unspecified

2.4

20.7

172

717

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.7

20.6

140

520

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

20.5

909

6570

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

6.6

20.3

A03

ICPC

Fever

1.6

20.2

535

3437

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.9

20.2

303

1633

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

20.1

1513

12028

M10.9

ICD-10 Finland

Gout, unspecified

1.8

20.1

350

1989

C08CA01

ATC

amlodipine; oral

1.3

20.0

1762

14359

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.5

19.9

163

673

J01MA14

ATC

moxifloxacin; systemic

1.7

19.9

413

2480

57708

ICD-8 Finland

Diseases of pancreas, Pancreatitis acuta alia

+∞

19.8

57609

ICD-8 Finland

Other diseases of gallbladder and biliary, Alii definiti sive NUD

+∞

19.8

N05AH04

ATC

quetiapine; oral

1.5

19.7

637

4297

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

19.6

501

3186

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

105.4

19.6

SPAT1097

SPAT

Recording of ECG

1.5

19.5

709

4911

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

19.5

195

890

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

19.5

1293

10056

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.1

19.5

187

B81

ICPC

Anaemia vit B12/folate deficiency

2.2

19.3

202

942

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

19.3

605

4048

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

19.2

420

2557

C07AB02

ATC

metoprolol; systemic

1.4

19.2

1159

8868

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

19.1

1094

8293

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.3

19.0

181

806

A10BH05

ATC

linagliptin; oral

2.0

18.6

251

1302

WX290

NOMESCO Finland

Other blockade of nerve

1.3

18.5

1522

12234

JN4AD

NOMESCO Finland

Body CT examination

1.8

18.4

356

2089

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

4.4

18.4

155

UJD02

NOMESCO Finland

Gastroscopy

2.0

18.3

238

1216

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.0

18.2

108

370

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

4.8

18.1

126

A10BK03

ATC

empagliflozin; oral

1.9

18.1

284

1555

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

17.9

1479

11883

I50.0

ICD-10 Finland

Congestive heart failure

1.6

17.9

462

2942

WX892

NOMESCO Finland

Monitored bed care

1.7

17.9

352

2076

N06AX21

ATC

duloxetine; oral

1.7

17.9

392

2389

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

17.8

335

1950

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

26.8

17.8

N06AA09

ATC

amitriptyline; systemic

1.6

17.7

438

2759

WX722

NOMESCO Finland

PEEP

2.0

17.7

231

1181

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.1

17.7

195

930

SPAT1104

SPAT

Monitoring of emergency patient

1.8

17.7

309

1754

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

17.7

281

1548

K65.0

ICD-10 Finland

Acute peritonitis

3.6

17.6

220

A03DA02

ATC

pitofenone and analgesics; systemic

2.8

17.6

112

399

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

14.6

17.6

SPAT1260

SPAT

Consultation of another employee

1.4

17.4

774

5584

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

17.3

1497

12097

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

17.3

370

2235

R05FB02

ATC

cough suppressants and expectorants

1.3

17.3

1766

14622

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

17.3

339

1996

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.7

17.3

383

2340

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.1

17.3

206

1018

D06

ICPC

Abdominal pain localized other

1.8

17.1

302

1724

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

17.1

880

6528

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.8

17.0

113

414

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

17.0

219

1116

JN4BD

NOMESCO Finland

Extensive body CT

1.6

16.9

509

3372

A04

ICPC

Weakness/tiredness general

1.5

16.8

573

3908

M03BX02

ATC

tizanidine; oral

1.3

16.7

2479

21542

WZC30

NOMESCO Finland

Teaching

1.5

16.7

536

3603

JLB12

NOMESCO Finland

Transduodenal endoscopic incision of pancreatic duct orifice

+∞

16.7

JKE15

NOMESCO Finland

Endoscopic lithotripsy in bile duct

+∞

16.7

AN1

Coronary angiography

1.5

16.6

623

4340

N30.0

ICD-10 Finland

Acute cystitis

1.5

16.5

589

4054

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.7

16.4

326

1930

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.6

16.4

395

2470

N05BA04

ATC

oxazepam; oral

1.4

16.2

1077

8342

SPAT1310

SPAT

Counselling related to known health issue

1.3

16.2

1356

10889

R02

ICPC

Shortness of breath/dyspnoea

1.5

16.1

512

3433

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

16.1

323

1918

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

16.1

168

783

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

4.4

16.0

134

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

16.0

1303

10413

WVA20

NOMESCO Finland

Medicine administration

2.8

16.0

103

372

A10BB12

ATC

glimepiride; oral

1.6

16.0

407

2585

JAF10

NOMESCO Finland

Repair of umbilical hernia

2.7

15.8

106

391

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

15.8

1656

13720

A01

ICPC

Pain general/multiple sites

1.7

15.7

325

1947

M01AX17

ATC

nimesulide; oral

1.3

15.7

1113

8706

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

15.7

371

2310

57402

ICD-8 Finland

Cholelithiasis, Cum cholecystitide et choledocholithiasi

+∞

15.6

JK3PB

NOMESCO Finland

Peroperative cholangiography

+∞

15.6

N06AB04

ATC

citalopram; systemic

1.4

15.6

919

6972

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.9

15.6

220

1160

107

Kela drug reimbursment

Pernicious anaemia

2.5

15.6

126

519

N05CD07

ATC

temazepam; oral

1.5

15.5

667

4774

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

15.5

251

1391

C09AA05

ATC

ramipril; oral

1.3

15.5

1260

10062

R07.3

ICD-10 Finland

Other chest pain

1.6

15.5

397

2524

R51.80

ICD-10 Finland

Headache

1.5

15.5

506

3418

N06AB10

ATC

escitalopram; oral

1.4

15.5

694

5011

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

15.4

207

1072

B01AB10

ATC

tinzaparin; parenteral

1.7

15.4

299

1758

N06AX16

ATC

venlafaxine; oral

1.6

15.3

460

3043

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

4.3

15.3

131

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

15.2

338

2069

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

15.2

1140

8991

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

3.4

15.1

217

JLC30

NOMESCO Finland

Pancreatoduodenectomy

13.1

15.1

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

15.1

286

1668

I81

ICD-10 Finland

Portal vein thrombosis

7.8

15.0

R42

ICD-10 Finland

Dizziness and giddiness

1.4

15.0

1009

7816

N05BA01

ATC

diazepam; systemic, rectal

1.5

14.9

583

4093

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

14.9

266

1523

A07AA02

ATC

nystatin; oral

1.8

14.9

282

1646

K92.1

ICD-10 Finland

Melaena

1.8

14.9

273

1577

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

14.8

732

5376

M01AH02

ATC

rofecoxib; oral

1.5

14.8

605

4286

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

56.8

14.8

T82

ICPC

Obesity

2.4

14.7

127

542

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

+∞

14.6

57600

ICD-8 Finland

Other diseases of gallbladder and biliary, Cholesterosis vesicae felleae

+∞

14.6

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

14.6

804

6026

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

14.6

4052

37738

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

14.6

815

6121

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.2

14.5

241

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

14.3

1216

9754

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.0

14.3

181

915

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

14.2

249

1417

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

14.1

838

6357

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

14.1

110

444

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.8

14.1

329

M01AH01

ATC

celecoxib; oral (coxibs)

1.4

14.0

760

5675

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

14.0

325

2012

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

14.0

333

2075

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.2

14.0

141

647

G04CA02

ATC

tamsulosin; oral

1.3

13.8

1282

10406

WX872

NOMESCO Finland

Intensive care

1.8

13.7

225

1254

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.0

13.7

183

950

I20.09

ICD-10 Finland

Unstable angina

1.7

13.7

305

1870

R4110

NOMESCO Finland

Physiotherapy

1.3

13.6

1109

8835

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

13.6

457

3102

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

13.6

461

3134

R05

ICPC

Cough

1.4

13.6

863

6613

5770F

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA RECIDIVANS]

+∞

13.5

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.0

13.4

174

892

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

13.3

1080

8595

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

13.3

503

3503

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

13.3

156

769

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.2

13.3

134

618

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

4.7

13.3

160

Kela drug reimbursment

exenatide

2.7

13.3

320

C23

ICD-10 Finland

Malignant neoplasm of gallbladder

13.8

13.2

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

13.2

235

1346

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

13.2

268

1597

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

13.1

291

1780

B01AC04

ATC

clopidogrel; oral

1.4

13.1

802

6111

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

9.3

12.9

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

12.8

272

1643

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

12.8

157

788

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

12.8

1110

8911

UKC02

NOMESCO Finland

Cystoscopy

1.4

12.8

810

6204

SPAT1312

SPAT

General health counselling

1.3

12.8

1269

10381

Angiography of the heart and coronary arteries

1.6

12.8

379

2502

R03BB04

ATC

tiotropium bromide; inhalant

1.5

12.7

510

3594

J02AC01

ATC

fluconazole; systemic

1.3

12.7

1431

11892

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

12.7

911

7114

L03

ICPC

Low back symptom/complaint

1.3

12.7

898

6998

G44.2

ICD-10 Finland

Tension-type headache

1.5

12.7

450

3094

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

4.7

12.7

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.0

12.6

241

K82.9

ICD-10 Finland

Disease of gallbladder, unspecified

70.0

12.6

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.7

12.5

243

1430

K82.0

ICD-10 Finland

Obstruction of gallbladder

+∞

12.5

K83.3

ICD-10 Finland

Fistula of bile duct

+∞

12.5

H03AA01

ATC

levothyroxine sodium; systemic

1.3

12.5

922

7226

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

12.5

2011

17437

N03AX09

ATC

lamotrigine; oral

2.0

12.4

147

727

XX9TE

NOMESCO Finland

Compementary ultrasound examination

5.1

12.4

A29

ICPC

General symptom/complaint other

1.5

12.3

477

3339

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

12.3

1011

8050

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

12.3

159

813

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.5

12.3

445

3070

ZX120

NOMESCO Finland

Intravenous

1.5

12.2

394

2649

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

7.1

12.2

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.6

12.2

341

R03BA05

ATC

fluticasone; inhalant

1.4

12.2

705

5315

-50

ICPC

Medication/prescr/renewal

1.8

12.2

194

1071

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

12.1

408

2771

A02BA04

ATC

nizatidine; systemic

1.5

12.1

373

2486

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.7

12.0

228

1332

R55

ICD-10 Finland

Syncope and collapse

1.4

12.0

513

3660

D11

ICPC

Diarrhoea

1.5

12.0

369

2455

SPAT1325

SPAT

Vaccination

1.3

12.0

1581

13376

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

2.2

12.0

122

565

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

12.0

291

1827

M01AB05

ATC

diclofenac; systemic, rectal

1.2

11.8

2856

25809

S06.0

ICD-10 Finland

Concussion

1.5

11.8

399

2712

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

11.8

518

3720

EBA00

NOMESCO Finland

Extraction of tooth

1.3

11.7

1245

10253

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

11.7

713

5419

H02AB04

ATC

methylprednisolone; systemic

1.4

11.7

602

4448

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

11.6

928

7356

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

11.6

408

2800

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

11.6

1022

8211

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

4.1

11.5

109

SGA01

NOMESCO Finland

Tooth opening as first aid

1.4

11.5

487

3467

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.7

11.5

134

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

11.4

450

3161

A10BJ02

ATC

liraglutide; parenteral

2.5

11.4

368

J01CA08

ATC

pivmecillinam; oral

1.3

11.4

1521

12880

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

11.3

2105

18478

J46

ICD-10 Finland

Status asthmaticus

2.2

11.3

118

554

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

11.3

482

3439

K76.9

ICD-10 Finland

Liver disease, unspecified

3.2

11.3

178

A10BX07

ATC

[U] liraglutide; parenteral

3.2

11.3

184

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

11.1

356

2389

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.3

11.1

426

PD5AD

NOMESCO Finland

CT of aorta

2.6

11.1

301

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

5.4

11.0

Z51.5

ICD-10 Finland

Palliative care

1.6

11.0

276

1747

R03BA01

ATC

beclometasone; inhalant

1.4

11.0

579

4298

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.6

10.9

258

1606

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

4.8

10.9

H02AB09

ATC

hydrocortisone; systemic

2.4

10.9

377

K02.1

ICD-10 Finland

Caries of dentine

1.2

10.9

2090

18382

TK800

NOMESCO Finland

Hemodialysis

2.4

10.9

398

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

10.9

376

2568

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

10.9

1526

12982

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.2

10.8

102

459

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

10.8

252

1564

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.2

10.8

168

M10.0

ICD-10 Finland

Idiopathic gout

1.9

10.8

149

783

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

10.7

329

2186

8140/3-C23.9

ICD-O-3

Adenocarcinoma, NOS, of gallbladder

28.0

10.7

M02AA07

ATC

piroxicam; topical

1.2

10.7

1634

14023

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

3.3

10.6

154

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

10.6

278

1780

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

10.6

691

5310

SPAT1059

SPAT

Spirometry at the office

1.7

10.5

209

1241

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.4

10.5

381

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

10.5

402

2808

KH1AD

NOMESCO Finland

CT of urinary organs

2.0

10.5

126

630

A03FA02

ATC

cisapride; oral, rectal

1.5

10.5

354

2405

A12BA01

ATC

potassium chloride; oral

1.6

10.5

266

1689

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.7

10.5

220

1328

SPAT1240

SPAT

Therapeutic discussion

1.6

10.4

303

1989

R96

ICPC

Asthma

1.5

10.4

318

2113

6664

FHL

Cholecystectomy and choledocotomy

110.2

10.4

JKB21

NOMESCO Finland

Laparoscopic cholangioscopy

110.2

10.4

5740B

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder with acute cholecystitis[CHOLECYSTOLITHIASIS CUM CHOLECYSTITIDE AC,CUM OBSTR]

+∞

10.4

SPAT1234

SPAT

Support of social functional capacity

1.6

10.4

241

1494

D10

ICPC

Vomiting

1.9

10.4

148

788

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.7

10.3

116

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

10.3

687

5292

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

32.6

10.3

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.9

10.3

207

E66

ICD-10 Finland

Obesity

2.0

10.3

135

698

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

3.0

10.3

200

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

10.3

143

755

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.1

10.3

110

524

N03AE01

ATC

clonazepam; systemic

1.7

10.2

228

1398

H25.8

ICD-10 Finland

Other senile cataract

1.4

10.2

550

4092

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.5

10.2

310

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

10.2

136

706

L15

ICPC

Knee symptom/complaint

1.3

10.2

791

6239

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

3.4

10.1

139

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.3

10.1

370

K75.0

ICD-10 Finland

Abscess of liver

7.9

10.1

ZXA10

NOMESCO Finland

Bilateral

1.3

10.0

795

6282

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

10.0

1050

8611

N19

ICD-10 Finland

Unspecified kidney failure

1.8

10.0

170

960

R4190

NOMESCO Finland

Nutritional therapy

2.1

10.0

109

525

S97

ICPC

Chronic ulcer skin

1.6

10.0

240

1504

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.5

10.0

320

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

1.8

10.0

164

919

M48.0

ICD-10 Finland

Spinal stenosis

1.4

9.9

531

3948

A10BB01

ATC

glibenclamide; oral

1.6

9.9

265

1707

R03AC03

ATC

terbutaline; inhalant

1.4

9.9

532

3957

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.8

9.9

214

K92.0

ICD-10 Finland

Haematemesis

2.0

9.9

121

610

M25.5

ICD-10 Finland

Pain in joint

1.3

9.9

1001

8174

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

9.9

185

1081

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

3.3

9.8

142

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.2

9.8

1270

10677

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

26.0

9.8

C09AA02

ATC

enalapril; systemic

1.3

9.8

989

8072

JFB00

NOMESCO Finland

Partial resection of small intestine

2.5

9.7

310

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.0

9.7

124

634

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

9.7

211

1285

R06AE07

ATC

cetirizine; oral

1.2

9.7

1644

14231

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

9.7

229

1429

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.5

9.7

384

2700

N03AG01

ATC

valproic acid; systemic, rectal

1.6

9.7

224

1392

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

9.6

567

4283

K59.0

ICD-10 Finland

Constipation

1.6

9.6

235

1479

L17

ICPC

Foot/toe symptom/complaint

1.3

9.6

993

8123

H02AB07

ATC

prednisone; oral

1.3

9.6

614

4696

N05AA02

ATC

levomepromazine; systemic

1.8

9.6

163

923

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

9.6

460

3352

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.6

9.5

218

1350

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.7

9.5

231

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.6

9.5

259

1676

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

9.5

2731

24868

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

9.5

448

3258

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.4

9.5

418

3000

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.0

9.5

123

635

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.4

9.5

347

WX725

NOMESCO Finland

Noninvasive ventilation

1.8

9.5

169

970

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

5.7

9.5

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

9.5

1793

15691

SPAT1252

SPAT

Overall medication plan or its review

1.5

9.5

314

2128

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

9.4

261

1694

E87.5

ICD-10 Finland

Hyperkalaemia

2.2

9.4

390

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

9.4

300

2014

M01AH05

ATC

etoricoxib; oral

1.2

9.4

2300

20627

5745A

ICD-9 Finland

Cholelithiasis, Calculus of bile duct without mention of cholecystitis[CHOLEDOCHOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]

+∞

9.4

K57.1

ICD-10 Finland

Diverticular disease of small intestine without perforation or abscess

2.7

9.3

237

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

8.0

9.3

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

1.9

9.3

123

640

E87.6

ICD-10 Finland

Hypokalaemia

1.9

9.3

129

682

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

9.2

1752

15324

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

1.6

9.2

211

1311

N06AA12

ATC

doxepin; systemic

1.6

9.1

222

1398

S22.3

ICD-10 Finland

Fracture of rib

1.5

9.1

279

1856

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.8

9.1

202

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

7.7

9.1

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

9.1

393

2809

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.9

9.0

119

618

R31

ICD-10 Finland

Unspecified haematuria

1.4

9.0

472

3496

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.0

9.0

105

520

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

8.9

856

6934

SPAT1211

SPAT

Application of soft bandage

1.5

8.9

348

2439

A10BJ06

ATC

semaglutide; parenteral

2.0

8.9

105

522

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.1

8.9

101

496

A10BK01

ATC

dapagliflozin; oral

1.8

8.9

146

820

JN4CD

NOMESCO Finland

Very extensive body CT

1.8

8.9

162

937

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.7

8.9

190

1156

M79.7

ICD-10 Finland

Fibromyalgia

2.1

8.9

440

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

2.7

8.9

211

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.8

8.8

145

817

SPAT1202

SPAT

Intra-articular injection

1.8

8.8

143

802

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.0

8.8

104

520

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.6

8.8

218

1382

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

9.5

8.8

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.4

8.8

310

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

8.7

429

3144

K78

ICPC

Atrial fibrillation/flutter

1.4

8.7

370

2639

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

8.7

188

1148

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.8

8.7

151

862

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.1

8.7

151

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

8.7

313

2162

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

1.9

8.7

124

665

Z08

ICPC

Social welfare problem

3.0

8.6

163

I25.2

ICD-10 Finland

Old myocardial infarction

1.4

8.6

391

2823

I20.00

ICD-10 Finland

Unstable angina

1.7

8.6

165

973

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

8.6

932

7659

J01EA01

ATC

trimethoprim; systemic

1.2

8.6

1065

8893

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

8.6

109

560

P03

ICPC

Feeling depressed

1.6

8.5

225

1445

R03DC03

ATC

montelukast; oral

1.3

8.5

529

4026

J01FA15

ATC

telithromycin; oral

1.4

8.5

348

2466

JL5BM

NOMESCO Finland

Bile and pancreas ducts MRI examination with 3 Tesla magnet

27.5

8.5

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

3.0

8.5

154

N20.1

ICD-10 Finland

Calculus of ureter

1.8

8.5

147

840

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.7

8.4

170

1018

P76

ICPC

Depressive disorder

1.7

8.4

164

972

I20.01

ICD-10 Finland

Unstable angina

1.8

8.4

150

867

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.6

8.4

196

1223

SPAT1058

SPAT

PEF monitoring instruction

1.5

8.3

305

2113

L86

ICPC

Back syndrome with radiating pain

1.6

8.3

194

1206

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

1.8

8.3

146

837

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.8

8.3

131

725

JLB35

NOMESCO Finland

Transduodenal endoscopic extraction of foreign body from pancreatic duct

+∞

8.3

K82.4

ICD-10 Finland

Cholesterolosis of gallbladder

+∞

8.3

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.8

8.3

146

838

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.3

8.3

123

C10AA01

ATC

simvastatin; oral

1.2

8.3

2169

19491

Z00.0

ICD-10 Finland

General medical examination

1.3

8.3

713

5693

M01AE02

ATC

naproxen; oral, rectal

1.2

8.3

2275

20530

K70.1

ICD-10 Finland

Alcoholic hepatitis

4.3

8.3

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.8

8.3

131

730

A07AA09

ATC

vancomycin; oral

2.5

8.2

238

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.0

8.2

493

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.0

8.2

104

534

I50

ICD-10 Finland

Heart failure

1.7

8.2

168

1012

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.8

8.2

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

8.2

648

5117

L04AX01

ATC

azathioprine; systemic

1.8

8.1

144

830

L04AA06

ATC

mycophenolic acid; systemic

2.6

8.1

224

D51.0

ICD-10 Finland

Vitamin B12deficiency anaemia due to intrinsic factor deficiency

3.2

8.1

126

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

8.1

259

1744

R33

ICD-10 Finland

Retention of urine

1.4

8.0

392

2867

E86

ICD-10 Finland

Volume depletion

1.9

8.0

111

589

A08

ICPC

Swelling

1.7

8.0

171

1040

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.5

8.0

245

1631

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.1

8.0

447

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

8.0

254

1709

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3023368) Bacteria identified in Blood by Culture

2701

13687

2.76

313.30

5.3

4.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1309

4417

3.51

313.29

4.0

2.3

umol/l

11.6

7.9

4.32

1190

3777

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3977

23436

3.03

307.65

9.6

5.6

umol/l

14.3

11.5

17.06

3851

22104

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3031

13350

3.55

307.65

4.5

2.2

u/l

56.8

56.4

0.09

2913

12212

(3002256) Pathology report gross observation

1357

5743

2.76

210.95

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2386

13395

2.29

198.79

4.4

2.9

u/l

40.5

34.2

2.86

2249

12593

(3042936) Bacteria identified in Isolate by Culture

1423

6492

2.56

187.66

2.1

2.0

—

(3044640) Blood type and Crossmatch panel - Blood

2460

14569

2.16

173.68

3.1

2.5

—

(3032080) INR in Blood by Coagulation assay

3071

19933

2.10

168.79

13.1

10.0

inr

1.3

0.48

838

5480

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

986

3957

2.78

166.52

3.1

1.9

g/l

0.2

15.77

923

3617

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

936

3684

2.82

163.88

4.1

1.8

u/l

57.9

33.1

0.99

826

3110

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3157

21117

2.03

155.10

5.1

4.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4581

35304

2.22

151.16

12.0

7.0

u/l

97.4

77.4

62.24

4417

32919

(3013826) Glucose [Moles/volume] in Serum or Plasma

3805

27641

2.01

143.05

6.9

4.5

mmol/l

7.2

6.8

20.04

3678

25854

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2790

18626

1.92

129.81

5.1

3.9

ng/l

69.2

92.7

0.32

2171

13680

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1844

11117

1.95

112.78

3.1

2.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3982

30920

1.84

104.81

5.8

4.7

e6/l

1188.1

2332.7

1.04

102

466

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3611

27267

1.80

103.78

5.2

2.8

u/l

88.1

46.8

44.40

3398

24849

(3024561) Albumin [Mass/volume] in Serum or Plasma

2906

20608

1.79

103.22

6.5

4.4

g/l

33.3

35.0

38.38

2729

18868

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1405

8181

1.93

92.34

2.2

1.8

—

(3033658) Prothrombin time (PT) actual/Normal

1790

11348

1.82

89.59

5.9

3.7

83.8

86.5

4.16

1756

11036

(3014576) Chloride [Moles/volume] in Serum or Plasma

1114

6045

2.03

89.39

7.7

6.4

mmol/l

104.3

104.4

0.20

1081

5912

(3026008) Bacteria identified in Urine by Culture

2195

14872

1.75

86.91

3.6

3.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

727

3480

2.24

80.25

2.0

1.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

3359

25893

1.67

79.64

10.4

8.5

e9/l

4.8

4.2

21.42

3006

22405

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3146

24105

1.64

74.16

8.8

6.5

mmol/l

1.2

6.50

2686

20142

(3002582) Erythrocytes [#/volume] in Urine

2105

14597

1.68

73.45

4.0

3.3

e6/l

110.8

103.3

0.07

1726

11248

(3000570) Elastase.pancreatic [Mass/mass] in Stool

308

1014

3.15

72.48

1.5

1.3

ug/g

251.9

295.4

1.13

194

599

(3037467) Urinalysis macro (dipstick) panel - Urine

3915

31779

1.66

72.43

5.5

4.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

281

882

3.29

71.57

3.2

2.4

umol/l

34.8

34.6

0.04

242

730

(3007566) Smooth muscle Ab [Titer] in Serum

291

951

3.16

69.31

1.4

1.1

titre

94.8

89.1

0.09

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1068

6193

1.88

68.72

6.6

5.5

mmol/l

1.1

1.0

1.02

1001

5657

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2167

15354

1.64

68.27

3.6

3.1

ng/l

1892.0

1826.6

0.24

1884

13232

(3024980) IgG subclass 4 [Mass/volume] in Serum

195

498

4.01

67.57

2.0

1.4

g/l

0.9

0.8

0.22

146

381

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

637

3112

2.17

66.23

4.2

3.7

kpa

5.1

5.2

0.41

587

2849

(3034770) Mitochondria Ab [Titer] in Serum

285

950

3.10

65.61

1.4

1.1

titre

947.5

944.2

—

(3000850) Epithelial cells [#/volume] in Urine

1561

10252

1.70

65.31

3.1

2.6

e6/l

6.6

4.9

3.81

1386

8939

(3018095) Leukocytes [#/volume] in Urine

2303

16738

1.61

64.40

4.5

3.8

e6/l

126.6

109.8

0.29

1811

12033

(3009343) pH of Capillary blood

625

3071

2.15

63.95

4.2

3.7

7.4

0.96

387

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1228

7593

1.77

63.48

3.8

3.0

mmol/l

0.8

1.98

1159

6987

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

606

2966

2.16

62.57

4.2

3.6

mmol/l

1.7

1.8

0.19

438

2185

(3020779) Urea [Moles/volume] in Serum or Plasma

808

4403

1.96

62.23

7.7

6.5

mmol/l

11.0

10.9

0.16

768

4140

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2849

21882

1.57

62.16

8.1

5.8

mmol/l

1.2

9.71

2600

19567

(3003396) Base excess in Arterial blood by calculation

993

5794

1.85

62.07

8.1

6.5

mmol/l

1.1

0.15

791

4448

(3016502) Oxygen saturation in Arterial blood

910

5166

1.90

61.98

8.5

6.8

95.3

95.4

0.14

883

4947

(3006315) Basophils [#/volume] in Blood

2905

22424

1.57

61.91

6.5

5.5

e9/l

0.0

0.58

2532

19106

(3019198) Lymphocytes [#/volume] in Blood

2954

22908

1.57

61.54

6.6

5.6

e9/l

1.9

0.14

2624

19884

(3019069) Monocytes/100 leukocytes in Blood

2759

21090

1.57

61.10

7.2

6.1

8.5

8.8

5.03

2568

19523

(3002030) Lymphocytes/100 leukocytes in Blood

2808

21571

1.56

60.69

7.0

5.9

25.3

26.7

8.77

2602

19854

(3027801) Oxygen [Partial pressure] in Arterial blood

991

5817

1.84

60.64

8.1

6.4

kpa

11.5

12.1

4.34

948

5488

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

991

5820

1.84

60.53

8.1

6.5

kpa

5.0

5.1

0.54

948

5500

(3001604) Monocytes [#/volume] in Blood

2883

22291

1.56

60.46

6.5

5.5

e9/l

0.6

2.15

2523

18973

(3013115) Eosinophils [#/volume] in Blood

2973

23160

1.56

60.20

6.8

5.7

e9/l

0.2

0.41

2610

20046

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

247

797

3.19

60.05

4.1

2.9

u/ml

256.0

1058.1

1.34

231

727

(3006504) Eosinophils/100 leukocytes in Blood

2738

20976

1.56

59.48

6.9

5.8

2.8

2.9

1.49

2546

19347

(3026782) Osmolality of Urine

1453

9567

1.68

59.30

3.5

2.8

mosm/kgh2o

546.0

551.5

0.43

1280

8080

(3022096) Basophils/100 leukocytes in Blood

2672

20393

1.56

58.82

6.8

5.8

0.6

0.7

1.52

2481

18819

(3022948) Iron [Moles/volume] in Serum or Plasma

1220

7677

1.74

58.76

2.9

2.5

umol/l

12.0

12.4

0.99

1121

7038

(3018010) Neutrophils/100 leukocytes in Blood

2756

21235

1.55

57.76

6.8

5.7

59.6

58.1

7.72

2569

19646

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1084

6651

1.77

56.86

2.9

2.6

21.6

22.0

0.35

923

5590

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1433

9499

1.67

56.60

4.8

3.9

ng/l

310.5

486.5

0.75

1153

7885

(3022217) INR in Platelet poor plasma by Coagulation assay

1160

7313

1.72

55.09

30.2

28.2

inr

1.5

0.04

195

998

(3002173) Hemoglobin [Mass/volume] in Arterial blood

821

4672

1.88

55.03

8.9

7.3

g/l

118.6

120.6

1.99

801

4491

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

451

2064

2.28

54.71

2.3

1.9

ug/l

2.2

2.5

0.25

401

1767

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1131

7096

1.73

54.60

2.9

2.5

g/l

2.3

0.06

1045

6504

(3005719) IgG [Mass/volume] in Serum or Plasma

588

2994

2.07

54.43

2.8

2.7

g/l

10.8

10.6

0.43

525

2724

(3030467) Casts [#/volume] in Urine by Automated count

1866

13319

1.58

53.98

3.9

3.2

e6/l

0.5

0.10

1492

10085

(3014111) Lactate [Moles/volume] in Serum or Plasma

765

4295

1.89

53.37

6.7

6.3

mmol/l

1.4

0.91

732

4100

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1421

9577

1.63

51.89

1.8

1.7

mg/l

1.4

0.08

1115

7361

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

934

5645

1.77

51.10

2.1

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

797

4630

1.83

49.68

4.6

3.6

kpa

5.8

1.32

774

4468

(3028026) IgM [Mass/volume] in Serum or Plasma

481

2354

2.13

49.29

1.8

1.9

g/l

1.3

1.4

1.01

424

2115

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

555

2898

2.01

47.69

1.6

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

919

5636

1.74

47.50

2.1

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2001

14839

1.52

47.27

4.3

3.9

mg/mmol

13.9

9.6

2.34

1329

9348

(3002032) Base excess in Venous blood by calculation

787

4623

1.81

47.14

4.6

3.6

mmol/l

1.9

0.04

655

3698

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

339

1465

2.39

46.83

1.4

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5007

44960

1.66

46.57

27.5

15.2

mg/l

35.3

25.7

51.46

4621

35960

(3009261) Glucose [Presence] in Urine by Test strip

2812

22436

1.47

45.87

4.8

3.8

estimate

0.0

0.15

525

3962

(3035350) Ketones [Presence] in Urine by Test strip

2778

22119

1.47

45.76

4.7

3.8

estimate

0.0

0.80

534

4015

(3021601) Nitrite [Presence] in Urine by Test strip

2776

22152

1.47

44.90

6.2

5.0

estimate

0.0

0.50

558

4057

(3017143) Hepatitis C virus Ab [Presence] in Serum

677

3865

1.85

44.36

1.6

1.5

—

(3013512) EKG study

1893

14030

1.51

44.14

5.2

4.2

—

(3012516) Albumin [Mass/volume] in Urine

1892

14046

1.50

43.66

3.5

3.2

mg/l

509.3

337.2

0.77

1280

8905

(3019060) Gas panel - Arterial blood

610

3386

1.89

43.63

6.6

4.4

—

(36304419) Bacteria [Presence] in Urine

1761

12882

1.52

43.60

3.8

3.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1741

12708

1.52

43.54

2.7

2.2

mg/l

3.3

3.0

4.37

1503

10666

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

333

1474

2.33

43.52

3.6

2.8

u/ml

297.6

1700.5

1.04

285

1243

(3013707) Erythrocyte sedimentation rate by Westergren method

3913

33474

1.48

43.47

4.8

4.0

mm/h

16.6

13.4

23.90

3601

30642

(3000991) Gas panel - Venous blood

694

4028

1.82

43.03

8.3

7.6

—

(3009508) Creatinine [Moles/volume] in Urine

1941

14527

1.49

42.88

3.6

3.1

mmol/l

7.4

0.04

1604

12029

(42870588) Differential panel, method unspecified - Blood

2052

15545

1.48

42.62

6.5

5.6

—

(3022313) Gas panel - Capillary blood

442

2221

2.07

42.08

4.4

3.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2210

17033

1.47

41.85

5.1

4.1

—

(40768797) Stomach Pathology biopsy report

936

5956

1.68

41.80

1.3

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

655

3782

1.82

41.22

3.8

3.0

kpa

4.5

0.21

635

3632

(3016650) Hepatitis A virus Ab [Presence] in Serum

171

556

3.14

41.05

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

426

2140

2.07

40.56

2.2

2.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

550

3022

1.90

40.48

1.9

1.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

761

4616

1.74

40.44

2.8

2.3

ug/l

5.1

7.2

3.60

649

3929

(3037522) Nuclear Ab [Titer] in Serum

848

5312

1.69

40.05

1.4

1.3

titre

601.5

494.3

0.71

187

1124

(3006922) Hepatitis E virus Ab [Presence] in Serum

198

4.65

38.88

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

307

1377

2.29

38.88

1.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

934

6045

1.64

38.80

2.9

2.3

1.8

1.22

831

5258

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

394

1959

2.08

38.53

2.1

1.8

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2389

18903

1.44

38.38

3.4

2.8

ug/l

161.0

140.9

1.79

2190

17188

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1927

14732

1.45

36.88

2.3

2.1

u/l

226.8

218.1

0.10

1809

13706

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2538

20416

1.42

36.66

2.3

2.0

pmol/l

89.3

94.4

6.46

1509

10484

(3007853) Bacteria identified in Skin by Aerobe culture

842

5385

1.65

36.49

2.2

1.8

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

561

3209

1.82

36.22

10.0

6.3

mmol/l

24.5

24.6

0.18

534

2980

(3026493) Urate [Moles/volume] in Serum or Plasma

1651

12292

1.47

36.12

3.1

2.7

umol/l

3740.2

5931.1

1.44

1412

10459

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

117

327

3.63

35.72

1.8

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

375

1893

2.05

35.16

4.7

4.0

mmol/l

24.7

24.9

0.49

348

1704

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

772

4877

1.67

34.99

4.0

3.9

ug/l

16.2

24.1

0.77

662

3969

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

165

582

2.89

34.37

1.1

—

(40758558) Short blood count panel - Blood

1537

11393

1.47

34.03

7.9

6.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1413

10307

1.48

33.93

2.0

1.8

nmol/l

1158.0

1158.3

0.00

1129

7615

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

873

5779

1.60

32.62

4.1

u/l

246.8

246.5

0.02

814

5412

(3015235) Bicarbonate [Moles/volume] in Capillary blood

277

1281

2.22

32.57

3.3

3.1

mmol/l

24.5

24.9

0.69

240

1107

(3019550) Sodium [Moles/volume] in Serum or Plasma

5101

46955

1.55

32.47

30.5

18.0

mmol/l

139.4

139.6

10.11

5014

45624

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

726

4617

1.65

31.89

1.6

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

515

2994

1.79

31.36

4.3

3.2

g/l

125.5

127.9

1.43

504

2919

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1084

7616

1.52

30.88

2.3

2.0

30.6

30.0

1.81

1046

7364

(3023103) Potassium [Moles/volume] in Serum or Plasma

5099

47066

1.53

30.62

30.6

18.1

mmol/l

4.0

5.35

5004

45658

(3027273) Bicarbonate [Moles/volume] in Venous blood

440

2458

1.85

30.53

4.8

3.3

mmol/l

25.1

25.2

0.04

427

2377

(3007164) IgA [Mass/volume] in Serum or Plasma

1050

7347

1.52

30.45

1.6

1.5

g/l

2.6

2.5

0.95

671

4312

(3030981) Hyaline casts [#/volume] in Urine by Automated count

457

2595

1.82

30.07

3.2

2.9

e6/l

0.3

0.00

448

2533

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

189

4.22

30.00

1.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1134

8090

1.49

29.90

3.2

2.9

e6/l

1.5

1.1

1.42

694

4690

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

463

2645

1.81

29.86

11.0

8.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

190

4.20

29.80

1.0

—

(3023520) Reticulocytes [#/volume] in Blood

708

4550

1.63

29.72

2.9

2.5

e9/l

69.9

67.9

0.70

551

3446

(3028192) IgG subclass 2 [Mass/volume] in Serum

109

330

3.34

29.49

1.8

1.2

g/l

3.2

2.9

0.57

234

(3027135) IgG subclass 1 [Mass/volume] in Serum

109

330

3.34

29.49

1.8

1.2

g/l

7.0

6.8

0.26

232

(3024139) IgG subclass 3 [Mass/volume] in Serum

109

330

3.34

29.49

1.8

1.2

g/l

0.5

0.4

1.05

235

(3029937) Albumin [Presence] in Urine by Test strip

1596

12181

1.42

29.42

5.3

4.2

estimate

0.0

1.28

514

3880

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1069

7572

1.50

29.10

3.5

3.1

e6/l

2.9

2.2

1.60

637

4209

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

161

613

2.67

29.05

5.7

5.9

mg/l

12.1

12.0

0.07

141

557

(4062490)

109

334

3.30

28.94

1.8

1.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

473

2749

1.78

28.77

6.9

mmol/l

24.8

0.08

468

2723

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

239

3.72

28.09

1.7

1.1

titre

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1408

10599

1.43

27.77

1.9

1.7

pmol/l

16522897.3

32196344.2

0.79

1156

8616

(3025941) Bacteria identified in Stool by Culture

401

2252

1.84

27.31

1.3

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

360

1966

1.88

26.78

1.7

1.6

u/ml

6.6

21.4

1.85

(3017181) Myelocytes/100 leukocytes in Blood

597

3772

1.65

26.69

4.6

4.0

0.9

1.0

0.18

216

1096

(3021960) Folate [Moles/volume] in Serum or Plasma

1530

11759

1.40

26.62

1.7

1.6

nmol/l

20.1

0.01

1322

10000

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

377

2095

1.85

26.55

6.8

4.8

1.7

1.6

0.38

360

1951

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2845

24123

1.34

26.36

2.9

2.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1508

11588

1.40

26.19

4.5

3.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1245

9250

1.44

26.17

5.3

4.4

—

(3019150) Specific gravity of Urine by Refractometry

1317

9905

1.42

25.83

5.3

4.3

kg/l

1.0

0.94

208

1511

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

184

793

2.36

25.58

6.1

4.9

iu/ml

546.2

412.9

0.20

118

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

448

2650

1.75

25.58

8.7

8.3

mmol/l

24.2

24.3

0.46

417

2425

(3020891) Body temperature

359

1996

1.85

25.23

6.7

4.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

368

2067

1.83

25.03

7.1

4.9

0.9

0.21

351

1927

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2245

18480

1.34

25.00

2.5

2.2

nmol/l

74.9

78.9

8.62

2007

16231

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

336

1840

1.87

24.77

3.2

2.7

u/ml

0.3

0.00

202

1045

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

391

2244

1.79

24.76

3.3

2.5

0.7

0.64

381

2145

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

696

4649

1.56

24.58

3.4

3.0

ng/l

218.8

247.4

0.97

633

4231

(3018418) pH of Serum or Plasma

1786

14246

1.36

24.31

4.6

3.9

7.4

0.35

374

2643

(3028626) Oxygen [Partial pressure] in Capillary blood

227

1092

2.12

24.19

3.1

2.9

kpa

8.0

7.9

0.39

211

1015

(3002179) Metamyelocytes/100 leukocytes in Blood

539

3421

1.63

23.57

4.4

3.9

0.7

0.08

146

792

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

300

3.17

23.42

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4574

41939

1.37

23.36

23.1

14.5

ml/min/173m2

75.4

76.1

1.09

3956

34614

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3766

33562

1.32

23.23

4.2

3.8

pmol/l

15.0

14.9

1.81

3394

30032

(3015377) Calcium [Moles/volume] in Serum or Plasma

1989

16216

1.34

23.16

3.6

3.3

mmol/l

2.3

2.4

5.92

1716

13860

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

288

1534

1.92

23.11

1.7

1.6

titre

140.0

315.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

638

4260

1.56

22.48

2.2

2.5

g/l

65.7

66.0

0.29

566

3782

(3043409) Potassium [Moles/volume] in Arterial blood

284

1522

1.91

22.38

6.0

3.8

mmol/l

3.8

3.9

1.02

261

1427

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

125

479

2.64

22.35

2.9

3.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

555

3593

1.60

22.34

4.8

4.1

0.1

2.48

203

1016

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

238

1203

2.02

22.22

2.9

2.3

g/l

3.8

3.6

0.96

228

1135

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4530

41580

1.36

22.17

7.7

6.0

mmol/mol

42.4

40.3

26.83

4167

37877

(3048689) Calprotectin [Mass/mass] in Stool

652

4402

1.54

21.82

2.4

2.1

ug/g

192.7

146.1

1.46

531

3408

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5078

47529

1.42

21.74

16.2

10.2

u/l

29.7

25.0

27.88

4950

45433

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

731

5076

1.50

21.41

4.7

3.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

126

498

2.56

21.18

1.1

g/l

1.6

1.5

0.86

116

447

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

405

2460

1.69

20.95

1.8

1.6

g/l

1.6

1.5

0.08

339

2085

(3004809) Band form neutrophils/100 leukocytes in Blood

173

807

2.18

19.99

3.4

3.6

1.5

1.6

0.16

128

596

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

609

4128

1.53

19.95

2.1

1.7

1.6

1.5

0.72

506

3553

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

142

611

2.36

19.89

3.1

2.5

u/ml

584.0

2697.0

1.02

(3025159) Blasts/100 leukocytes in Blood

514

3362

1.58

19.74

4.8

4.1

0.3

0.5

0.40

172

855

(3022145) Colonoscopy Study observation

680

4727

1.49

19.74

1.4

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

237

1249

1.93

19.66

1.4

iu/ml

9.8

20.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

564

3781

1.54

19.42

2.3

2.2

nmol/l

360.2

377.4

1.07

511

3455

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

157

717

2.22

19.14

1.5

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

157

717

2.22

19.14

1.5

1.4

u/ml

24.8

13.9

—

(3021901) Oxygen saturation in Capillary blood

190

936

2.06

19.08

2.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4438

40906

1.32

19.07

5.2

4.6

mu/l

2.0

2.1

0.74

4023

36836

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

377

2310

1.67

18.86

4.2

3.7

mmol/l

23.9

24.1

0.37

339

2060

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1100

8411

1.38

18.82

1.3

1.2

u/ml

1.2

1.9

1.87

285

2121

(3000494) Fungus identified in Specimen by Culture

715

5085

1.46

18.43

1.5

1.4

—

(1616796) Gas panel - Central venous blood

206

1076

1.95

17.57

4.1

3.7

—

(3010421) pH of Blood

231

1265

1.86

17.07

4.9

4.3

7.4

0.10

199

1062

(3004588) Protein electrophoresis panel - Serum or Plasma

525

3565

1.52

16.98

2.1

2.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

139

635

2.22

16.97

1.5

1.4

u/ml

105.9

115.2

0.48

147

(40768804) Tissue Pathology biopsy report

2152

18294

1.27

16.90

2.3

2.2

—

(40761511) CBC panel - Blood by Automated count

4925

46316

1.34

16.75

25.0

14.5

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

173

3.37

16.23

3.5

2.0

93.7

95.1

0.12

161

(3012501) Base excess in Blood by calculation

203

1086

1.90

16.15

4.9

4.4

mmol/l

2.5

2.7

0.51

138

742

(40761535) Cells panel - Urine sediment

590

4150

1.47

16.02

3.9

3.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

287

1713

1.71

15.85

2.3

2.2

ug/l

554.1

611.0

0.13

275

1610

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

140

662

2.14

15.72

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

217

1201

1.84

15.53

1.8

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

177

922

1.95

15.27

1.3

1.2

—

(3021589) Normoblasts [#/volume] in Blood

2275

19636

1.25

15.26

14.2

9.6

e9/l

0.0

1.00

1905

15956

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

205

1123

1.85

15.17

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

205

1123

1.85

15.17

1.5

1.3

—

(3019977) pH of Arterial blood

278

2.76

15.01

3.7

2.7

7.4

0.22

100

(40768441) Liver Pathology biopsy report

257

2.82

14.89

1.6

1.2

—

(3037756) Immunofixation for Serum or Plasma

196

1067

1.86

14.80

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1319

10711

1.30

14.46

4.5

3.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4655

43679

1.28

14.41

5.5

4.7

mmol/l

6.3

6.0

33.65

4221

39115

(46235355) HIV 1 and 2 tests - Meaningful Use set

740

5522

1.39

14.41

1.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

205

1145

1.82

14.27

2.4

2.2

g/l

128.4

127.8

0.10

157

809

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

137

670

2.07

14.13

1.3

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

521

3665

1.46

14.10

4.3

3.7

ng/l

102.4

94.0

1.09

456

3077

(3052851) Hemolysis interference index of Serum or Plasma

241

1420

1.73

13.98

4.1

3.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

430

2.32

13.71

1.3

1.2

u/l

58.0

62.3

0.32

292

(3047181) Lactate [Moles/volume] in Blood

257

1553

1.68

13.60

9.1

5.7

mmol/l

1.5

1.3

1.43

230

1364

(3000330) Specific gravity of Urine by Test strip

376

2494

1.54

13.54

4.8

3.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

232

1365

1.73

13.54

5.6

4.3

—

(40767503) Oxygen content in Capillary blood by calculation

192

1069

1.82

13.53

2.7

2.5

15.9

16.0

0.21

107

552

(3021879) Hepatitis B virus core Ab [Presence] in Serum

381

2537

1.54

13.48

1.3

1.4

—

(3019225) pH of Specimen

669

4973

1.39

13.29

5.7

4.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

204

1164

1.78

13.25

1.5

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

125

614

2.06

12.78

1.3

1.2

u/ml

285.9

280.6

0.06

375

(3017732) Neutrophils [#/volume] in Blood

436

3023

1.48

12.70

3.5

3.0

e9/l

4.4

4.2

0.96

316

2242

(3040151) Glucose [Moles/volume] in Capillary blood

120

582

2.08

12.69

21.9

7.7

mmol/l

7.9

7.4

0.60

106

470

(3007461) Platelets [#/volume] in Blood

5172

49407

1.32

12.66

37.5

22.4

e9/l

246.2

244.2

1.17

5063

47880

(3024731) MCV [Entitic volume]

5173

49421

1.32

12.63

37.3

22.3

91.2

91.5

4.22

5105

48472

(3035941) MCH [Entitic mass]

5173

49423

1.32

12.61

37.3

22.3

30.2

30.4

11.83

5105

48472

(3000963) Hemoglobin [Mass/volume] in Blood

5174

49435

1.32

12.60

37.8

22.5

g/l

130.7

133.9

37.10

5105

48494

(3026361) Erythrocytes [#/volume] in Blood

5173

49426

1.32

12.59

37.5

22.4

e12/l

4.4

13.54

5045

47729

(3010813) Leukocytes [#/volume] in Blood

5174

49442

1.32

12.54

37.5

22.4

e9/l

7.4

6.8

32.95

5050

47720

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

195

1120

1.77

12.41

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

208

1221

1.73

12.27

2.5

2.1

88.7

89.9

0.31

197

1144

(3008757) Leukocyte morphology finding [Identifier] in Blood

108

518

2.10

11.79

3.6

4.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4439

41726

1.24

11.75

4.5

4.0

mmol/l

1.4

1.3

35.22

4017

37457

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

298

2.47

11.65

1.2

1.3

mmol/l

11.6

11.9

0.10

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

341

2.36

11.62

1.5

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

138

3.20

11.46

4.7

2.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

138

3.20

11.46

4.7

2.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

191

1120

1.73

11.34

2.9

2.3

210.8

196.5

1.32

181

1063

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

267

2.53

11.27

1.1

1.0

mg/l

298.1

291.5

0.15

236

(44816559) Phosphatidylethanol [Mass/volume] in Blood

120

609

1.99

11.26

1.7

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

215

2.71

11.26

3.6

2.8

—

(3037121) Protein [Mass/volume] in Urine

264

1687

1.59

11.23

3.4

3.0

g/l

0.3

0.06

130

697

(3022621) pH of Urine by Test strip

436

3110

1.43

10.95

3.6

3.1

—

(3035285) Chloride [Moles/volume] in Venous blood

128

677

1.91

10.68

2.7

2.2

mmol/l

105.2

105.8

0.58

128

669

(3041354) Potassium [Moles/volume] in Venous blood

128

677

1.91

10.68

2.7

2.2

mmol/l

4.0

4.1

1.55

128

669

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

263

1700

1.57

10.67

3.0

3.2

mg/l

75.2

53.7

0.40

218

1366

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

336

2.31

10.64

1.5

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

263

1703

1.57

10.59

3.0

3.2

mg/l

81.0

91.6

0.10

222

1370

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

148

825

1.81

10.48

1.3

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

4.28

10.28

2.7

3.3

u/field

0.4

0.5

0.20

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

255

1657

1.56

10.12

2.9

3.2

ratio

1.4

3.8

1.30

120

(3036489) Thrombin time

243

1563

1.58

10.09

2.3

1.9

22.6

21.5

0.78

220

1384

(3024891) Influenza virus A+B Ag [Presence] in Specimen

185

1112

1.68

10.08

1.3

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

532

3983

1.37

10.06

4.3

3.9

mmol/l

1.2

1.33

477

3435

(3051387) C reactive protein [Mass/volume] in Capillary blood

177

1055

1.70

9.95

4.8

3.5

mg/l

28.6

29.3

0.08

131

666

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

169

996

1.72

9.90

1.8

1.3

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

207

2.62

9.87

1.1

u/l

102.5

90.6

0.32

155

(3033705) Calcium.ionized [Moles/volume] in Venous blood

124

667

1.88

9.86

2.7

2.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

138

772

1.81

9.69

2.1

u/l

353.4

4306.1

4.20

303

(3034274) Bile acid [Moles/volume] in Serum --fasting

276

2.37

9.60

2.7

1.9

umol/l

30.2

5.9

3.14

187

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

194

1197

1.64

9.57

1.4

1.5

g/l

0.2

0.53

186

1129

(3044889) 12 lead EKG panel

3483

32251

1.19

9.56

4.6

4.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.45

9.44

2.0

2.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

206

2.59

9.44

1.1

u/l

37.4

35.4

0.07

154

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

297

2.30

9.43

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

128

706

1.83

9.42

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

316

2.26

9.42

1.7

1.3

promille

1.4

1.1

0.71

245

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

137

772

1.79

9.40

1.2

1.3

u/l

63.9

42.3

0.33

119

668

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

261

2.39

9.34

2.1

1.9

u/field

1.5

2.1

0.66

193

(3009466) Valproate [Moles/volume] in Serum or Plasma

110

585

1.90

9.09

5.1

4.6

umol/l

352.5

349.7

0.08

496

(40760888) Immunoglobulin light chains.free panel - Serum

203

1286

1.60

9.02

3.2

3.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

166

1001

1.68

8.98

1.2

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

197

1241

1.61

8.97

1.4

1.5

g/l

1.2

1.54

189

1172

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

264

1779

1.51

8.91

2.0

1.8

u/l

39.3

38.7

0.15

225

1537

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

134

766

1.77

8.79

2.0

1.7

nmol/l

0.8

0.01

103

639

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

108

578

1.88

8.77

1.9

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

108

578

1.88

8.77

1.9

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

168

2.69

8.70

1.2

2.1

umol/l

110.3

145.0

0.34

101

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4581

43611

1.21

8.69

5.0

4.5

mmol/l

4.3

4.6

34.31

4208

39769

(3005988) Vibrio sp identified in Specimen by Organism specific culture

108

580

1.88

8.68

1.9

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

108

580

1.88

8.68

1.9

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

109

589

1.87

8.60

1.9

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

425

2.01

8.43

2.2

2.1

u/field

5.1

1.9

1.88

175

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4684

44726

1.21

8.41

5.4

5.0

mmol/l

2.5

2.7

24.28

4274

40563

(3042517) Benzodiazepines panel - Urine

7.51

8.41

2.1

1.9

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

249

2.34

8.41

1.6

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4539

43216

1.20

8.40

4.9

4.5

mmol/l

1.3

1.5

79.18

4122

39148

(40761536) Microorganisms panel - Urine sediment

500

3821

1.34

8.27

5.0

4.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

725

5828

1.28

8.24

5.0

4.6

31.5

33.2

3.89

530

3819

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

291

2034

1.45

8.20

2.1

2.3

g/l

7.6

7.5

0.53

197

1485

(3024928) Oxygen saturation in Venous blood

162

998

1.64

8.11

2.9

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

290

2031

1.45

8.09

2.1

2.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

9.10

8.08

2.0

—

(3039000) Anion gap in Blood

175

1100

1.61

8.08

11.3

6.5

mmol/l

11.6

11.3

0.43

163

973

(3018572) Chloride [Moles/volume] in Blood

175

1101

1.61

8.05

11.3

6.5

mmol/l

104.8

105.1

0.28

163

974

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

127

735

1.74

8.02

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

510

1.90

8.01

3.2

3.6

61.4

58.9

0.46

305

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

249

2.30

7.96

1.6

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

189

1215

1.57

7.94

1.6

1.5

iu/ml

0.7

8.3

0.90

278

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

256

2.28

7.91

1.4

1.6

u/l

7.9

6.0

0.32

124

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

105

578

1.83

7.85

1.9

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

288

2028

1.44

7.82

2.1

2.3

g/l

3.7

3.8

0.20

190

1424

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

178

1135

1.59

7.76

2.3

ug/min

146.4

104.3

0.57

659

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

114

646

1.78

7.75

1.3

1.4

—

(3003181) Sodium [Moles/volume] in Urine

145

880

1.66

7.71

1.8

1.3

mmol/l

59.3

63.2

0.59

117

704

(42529406) Shigella sp [Presence] in Stool by Culture

189

1226

1.56

7.65

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

188

1219

1.56

7.63

1.3

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1353

11716

1.20

7.60

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

140

849

1.66

7.48

1.6

1.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

118

684

1.74

7.44

1.4

1.5

e6/l

8588.8

2325.5

0.39

491

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1087

9239

1.21

7.41

3.3

3.0

mmol/l

2.5

1.57

923

7995

(3043410) Blood group antigens tested for on Red Blood Cells

125

2.81

7.40

2.0

1.9

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

297

2.13

7.35

1.3

1.2

titre

210.0

97.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

132

796

1.67

7.22

1.4

1.5

g/l

33.8

31.0

1.37

116

705

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

185

1211

1.54

7.22

1.3

1.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

110

631

1.76

7.21

2.5

2.3

32.9

32.6

0.31

110

626

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

268

1893

1.43

7.18

2.2

2.3

g/l

3.1

0.09

192

1453

(3001186) Copper [Moles/volume] in Serum or Plasma

3.12

7.12

1.6

1.1

umol/l

17.3

16.5

0.35

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

343

2.02

7.02

2.5

2.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

224

1536

1.48

7.02

1.2

u/ml

0.2

1.1

2.60

150

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

172

1117

1.56

6.97

2.2

1.8

mg/l

13.3

11.4

0.77

158

1029

(3010375) cycloSPORINE [Mass/volume] in Blood

148

2.58

6.84

27.9

25.4

ug/l

123.3

111.4

0.50

128

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

252

1785

1.43

6.67

2.5

2.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

491

1.82

6.67

1.6

1.5

—

(3042631) Mycobacterium sp identified in Specimen

118

708

1.68

6.61

2.4

2.9

—

(3014271) Vancomycin [Susceptibility]

324

2.02

6.59

2.8

2.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

206

2.29

6.58

1.3

1.2

—

(40757373) Influenza virus identified in Isolate

100

2.91

6.56

1.3

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

472

1.83

6.56

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

111

659

1.70

6.48

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

112

667

1.69

6.47

1.8

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

112

667

1.69

6.47

1.2

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

146

930

1.58

6.46

1.5

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

263

1889

1.41

6.46

2.1

2.3

g/l

10.9

10.2

1.26

213

1567

(4198724)

3.07

6.45

11.0

1.6

—

(3017704) Immunofixation for Urine

273

2.10

6.44

1.5

1.4

—

(3004451) EKG impression Narrative

241

2.17

6.38

1.5

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

314

2329

1.37

6.36

1.5

1.3

u/ml

271.5

230.8

0.47

289

2114

(44806118)

507

1.79

6.32

1.6

1.4

—

(44790047)

507

1.79

6.32

1.6

1.4

—

(44790048)

507

1.79

6.32

1.6

1.4

—

(44790049)

507

1.79

6.32

1.6

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

120

733

1.65

6.30

1.5

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

118

1884

0.62

6.27

1.4

1.5

—

(3035880) pH of Pleural fluid

310

2.01

6.25

1.1

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

139

883

1.59

6.24

1.2

1.4

e6/l

13.8

19.8

0.30

106

694

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

139

884

1.59

6.21

1.3

1.4

e6/l

1027.7

1172.7

0.06

114

728

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

244

2.14

6.20

1.5

1.2

u/l

39.6

22.9

0.83

206

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

332

1.97

6.18

1.3

1.2

—

(4035726)

514

4108

1.27

6.12

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

168

1119

1.52

6.11

1.4

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

286

2.04

6.09

2.6

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

169

1129

1.51

6.07

3.8

2.7

mg/l

1.7

1.6

0.55

158

1003

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

816

6876

1.22

6.01

1.3

iu/ml

46.7

36.1

0.59

245

2130

(3044242) Glucose [Moles/volume] in Arterial blood

254

2.10

6.00

2.2

2.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

684

5663

1.23

5.98

1.5

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

208

1453

1.45

5.98

1.5

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

105

629

1.68

5.96

1.4

e6/l

72878.5

65602.6

0.09

362

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

153

2.43

5.93

3.5

2.6

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

118

2.64

5.88

1.2

1.8

g/l

11.8

15.4

1.37

(3042733) HLA Ab [Presence] in Serum

2.82

5.82

3.9

5.0

—

(3045414) Leukocytes [Presence] in Urine

276

2036

1.37

5.81

2.3

1.9

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

376

1.87

5.76

1.2

1.3

nmol/l

1.3

1.5

0.41

332

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

111

683

1.64

5.71

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

768

6470

1.21

5.66

1.3

1.2

u/ml

14.5

12.4

0.30

299

2381

(3003338) MCHC [Mass/volume]

3882

36927

1.14

5.66

32.3

19.8

g/l

330.8

331.7

7.06

3838

36527

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

533

1.72

5.63

1.3

u/l

1041.9

401.2

0.58

504

(3027923) C peptide [Moles/volume] in Serum or Plasma

222

2.13

5.55

1.4

1.3

nmol/l

1.2

1.3

0.18

170

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

153

1024

1.51

5.48

1.2

mg/l

559.0

560.8

0.01

142

960

(3028707) Methadone [Presence] in Urine by Screen method

340

1.89

5.47

6.7

2.3

—

(3004775) Volume in Urine collected for unspecified duration

349

1.87

5.39

2.4

2.2

639.4

656.4

0.14

214

(3017569) Oxygen content in Arterial blood

253

2.02

5.31

1.9

2.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

244

1793

1.38

5.30

1.4

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

551

1.68

5.28

1.5

—

(3024932) HLA-DR beta [Type]

102

2.65

5.22

1.1

—

(4306422)

538

1.68

5.21

1.1

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

209

2.11

5.15

1.4

1.2

nmol/l

132.5

139.8

0.40

209

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

208

2851

0.72

5.13

1.7

1.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

339

2631

1.31

5.11

2.4

2.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

462

3729

1.26

5.10

3.3

2.7

ml/min/173m2

60.2

62.4

0.58

240

1526

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

224

2.06

5.05

1.3

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

520

1.68

5.05

1.9

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

171

1193

1.45

5.01

3.3

3.1

nmol/l

0.8

0.00

130

899

(3002385) Erythrocyte distribution width [Ratio]

3804

36263

1.13

5.01

30.2

18.5

14.2

13.8

29.89

3731

35348

(3045716) Anion gap in Serum or Plasma

225

2.05

5.00

1.4

2.2

mmol/l

9.5

9.2

0.15

177

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

121

787

1.55

4.98

3.8

2.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

170

1186

1.45

4.98

1.8

1.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

226

2.04

4.94

1.3

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

132

880

1.51

4.87

1.6

1.5

—

(3024471) HLA-A [Type]

106

2.55

4.87

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

101

2.58

4.79

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

528

1.66

4.79

2.1

2.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

119

2.44

4.78

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

233

1736

1.36

4.68

2.3

2.4

g/l

1.0

0.03

193

1451

(3016750) Collection duration of Urine

252

1.95

4.66

2.4

2.1

min

490.1

495.4

0.12

173

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

133

900

1.49

4.59

1.1

1.2

mmol/l

4.0

3.8

0.74

119

836

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

283

1.88

4.53

1.7

1.4

umol/l

13.6

0.02

262

(40768806) Pleura Pathology biopsy report

622

1.58

4.53

1.5

1.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.72

4.50

1.5

1.6

ng/l

110.2

147.3

0.80

(3006576) Bicarbonate [Moles/volume] in Blood

161

2.18

4.48

7.0

6.5

mmol/l

23.8

24.8

0.77

143

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

424

1.71

4.46

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

424

1.71

4.46

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

424

1.71

4.46

1.6

1.7

—

(3012441) Differential panel - Pleural fluid

609

1.59

4.45

1.4

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.93

4.43

12.6

13.5

mmol/l

4.4

5.6

1.48

(4010399)

397

3204

1.26

4.42

1.5

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2000

18442

1.13

4.41

5.1

5.3

ug/l

3.7

4.2

0.30

1783

16309

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

251

1.92

4.38

2.5

2.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

488

1.65

4.35

1.6

1.7

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

7.51

4.35

1.1

u/field

1.0

0.9

—

(3044927) Protein electrophoresis panel - Urine

550

1.61

4.35

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

420

1.70

4.33

1.3

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

123

830

1.49

4.32

1.2

1.3

miu/ml

203.1

210.4

0.07

344

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

261

1.88

4.24

2.7

2.4

e6/l

651.4

535.2

0.66

224

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

469

1.65

4.22

1.0

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

431

1.68

4.22

1.6

1.4

30.3

26.8

0.31

270

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

115

2.35

4.14

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

115

2.35

4.14

1.1

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

249

1.89

4.14

1.6

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

249

1.89

4.14

1.6

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

249

1.89

4.14

1.6

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

249

1.89

4.14

1.6

1.9

—

(3045788) Cell count panel - Pleural fluid

534

1.60

4.13

1.4

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

285

1.83

4.13

11.2

12.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.48

4.12

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

330

1.76

4.08

1.2

1.3

mmol/l

2.1

2.2

0.12

304

(44806420)

155

2.13

4.04

2.2

2.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

585

1.56

4.02

1.4

1.2

u/ml

3.9

2.8

0.34

181

(36660697) Celiac disease serology panel - Serum

373

3024

1.25

4.01

1.2

—

(3020491) Glucose [Moles/volume] in Blood

325

1.76

3.99

2.6

2.2

mmol/l

7.7

6.9

0.75

216

(21494755) Public health laboratory ask at order entry panel

208

2735

0.75

3.97

1.3

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

462

1.63

3.96

1.6

1.7

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

2.82

3.95

1.2

1.3

61.4

76.2

1.26

(3045142) Bone marrow Pathology biopsy report

549

1.57

3.93

1.2

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

123

849

1.46

3.90

1.3

u/l

11.4

10.2

0.43

692

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

278

1.80

3.82

2.7

2.3

e6/l

493.6

637.5

0.97

119

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

577

1.55

3.81

1.1

iu/ml

54.0

1105.8

0.51

120

(3023419) Bacteria identified in Sputum by Culture

625

1.53

3.81

2.3

2.5

—

(4146454)

531

1.57

3.77

2.9

2.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

100

667

1.51

3.77

2.6

2.0

mg/l

26.5

24.3

0.14

157

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

305

2435

1.27

3.77

3.1

3.2

pmol/l

4.3

4.4

1.11

274

2141

(4015189)

140

2.15

3.75

2.3

2.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

646

1.51

3.69

1.1

—

(3045424) Erythrocytes [Presence] in Urine

111

760

1.47

3.69

1.7

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

372

1.67

3.65

1.5

1.2

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

116

2.25

3.63

1.1

1.8

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

197

1.93

3.61

1.4

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

338

2746

1.24

3.60

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

199

1513

1.33

3.58

2.1

2.3

g/l

0.0

0.1

0.14

177

1359

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

208

1592

1.32

3.57

1.9

2.2

g/l

36.7

37.2

0.69

169

1327

(3034891) Synovial lining cells/100 cells in Synovial fluid

212

1.89

3.57

1.4

4.0

3.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.45

3.54

1.1

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

137

984

1.40

3.53

1.4

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

112

2.24

3.47

1.5

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

600

1.51

3.43

5.8

1.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.76

3.41

2.8

2.1

umol/l

17.5

18.0

0.05

(3051651) Icteric interference index of Serum or Plasma

274

1.76

3.40

4.1

3.1

—

(3011412) CD3 cells [#/volume] in Blood

380

1.64

3.39

2.7

2.3

e9/l

1.2

1.0

0.48

230

(3001893) Eosinophils/100 leukocytes in Pleural fluid

188

1.92

3.37

1.3

1.5

3.6

2.5

0.27

156

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

523

1.54

3.35

1.1

120.6

115.5

0.51

461

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

268

1.76

3.35

2.9

4.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

3.25

3.34

1.6

2.2

mmol/l

1.3

0.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

196

1.89

3.33

1.8

2.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

524

1.53

3.32

1.3

pmol/l

350.8

269.7

0.98

401

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

429

1.59

3.32

1.7

titre

1600.0

1292.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

153

1133

1.36

3.31

1.5

1.6

e6/l

23451.2

14976.5

0.97

110

820

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

501

1.54

3.30

1.3

nmol/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

231

1815

1.28

3.29

1.0

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

4115

39805

1.11

3.25

25.7

16.5

37.9

39.1

7.96

2584

26444

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

205

1.86

3.24

1.0

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

156

1.99

3.23

1.7

2.1

174.6

158.1

0.42

148

(3022493) Free Hemoglobin [Mass/volume] in Plasma

191

1.89

3.23

1.2

3.7

mg/l

76.9

69.5

0.12

132

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

129

2.10

3.23

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

577

1.50

3.21

1.3

nmol/l

0.2

0.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

449

1.57

3.20

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

325

1.67

3.19

1.2

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

157

1.98

3.18

1.8

2.3

e6/l

16649.7

5714.6

0.35

108

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

395

1.60

3.17

1.3

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

104

2.22

3.15

1.3

1.1

76.4

84.7

0.56

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

193

1.87

3.14

1.8

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

193

1.87

3.14

1.8

2.1

—

(4268621)

381

1.61

3.13

2.4

2.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

215

1.82

3.12

1.1

—

(3021788) Differential panel - Synovial fluid

116

831

1.40

3.09

1.3

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

558

1.49

3.08

1.5

64.8

63.7

0.09

363

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

165

1251

1.33

3.08

1.6

1.7

—

(40768443) Skin Pathology biopsy report

250

2002

1.26

3.07

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

129

943

1.38

3.05

1.2

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.23

3.05

1.3

g/l

20.6

28.4

1.38

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.45

3.04

1.0

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

408

1.57

3.03

1.3

u/l

21.1

13.6

0.52

376

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.26

3.02

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

695

6126

1.15

3.02

11.7

7.6

—

(3020393) Adenovirus Ag [Presence] in Stool

2.89

3.02

1.1

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

5.84

3.02

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.30

3.00

1.9

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

204

1.82

2.97

1.3

1.6

—

(3011288) Drugs identified in Urine by Screen method

522

1.50

2.97

8.7

2.5

—

(3044290) Cell count panel - Cerebral spinal fluid

113

812

1.40

2.97

1.2

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

3.00

2.96

1.1

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.64

2.96

1.2

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.64

2.96

1.2

1.1

103.1

98.4

0.29

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

162

1.92

2.93

2.5

—

(40768446) Kidney Pathology biopsy report

155

1.94

2.93

1.6

1.5

—

(3049717) Cytology report of Urine Cyto stain

264

2140

1.24

2.93

2.8

2.9

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

575

1.47

2.88

1.4

1.2

u/ml

5.8

4.4

0.33

240

(4024509)

494

1.50

2.87

1.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

543

1.48

2.86

1.2

1.1

u/ml

0.9

1.7

0.82

211

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

143

1.96

2.84

1.9

2.2

e6/l

7886.5

22605.1

0.55

(3039443) Prostate specific Ag panel - Serum or Plasma

758

0.62

2.82

1.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

196

1543

1.28

2.80

1.1

u/ml

2.3

1.2

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

2.64

2.79

1.0

1.1

ug/l

77.3

74.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

124

2.02

2.75

3.5

2.8

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

233

1.72

2.71

1.3

1.1

iu/ml

3.8

3.9

—

(3044941) Cell count panel - Synovial fluid

103

742

1.39

2.70

1.3

1.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

106

2.08

2.62

1.3

1.2

95.0

99.5

0.23

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

521

1.46

2.62

1.4

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.55

2.61

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.55

2.61

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.55

2.61

1.1

1.2

—

(3049242) von Willebrand panel - Platelet poor plasma

4.67

2.59

1.7

2.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

229

1.71

2.58

1.3

1.5

64.3

68.4

0.26

186

(3014891) Appearance of Pleural fluid

2.19

2.56

2.3

1.5

—

(3007463) Buprenorphine [Presence] in Urine

7.14

2.55

3.8

4.4

—

(3047189) Immunofixation for 24 hour Urine

254

1.66

2.51

1.4

1.7

—

(3033799) Differential panel - Peritoneal fluid

143

1.89

2.50

1.8

1.9

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

175

1381

1.27

2.49

2.0

2.3

g/l

0.0

0.00

156

1253

(3051611) Lipemic interference index of Serum or Plasma

494

1.46

2.49

3.8

3.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

544

1.44

2.48

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

163

1279

1.28

2.44

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

177

1406

1.27

2.40

2.0

2.3

g/l

0.0

0.76

156

1258

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

328

1.56

2.39

1.3

titre

58.0

74.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

591

1.41

2.37

1.3

1.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.42

2.36

2.4

2.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.64

2.36

1.0

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

104

2.02

2.35

1.3

74.4

83.4

0.43

(3000764) Benzodiazepines [Presence] in Urine

104

773

1.35

2.30

5.5

1.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

537

1.42

2.28

1.1

—

(3016879) Cocaine [Presence] in Urine

715

1.36

2.27

5.8

1.8

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.23

2.27

1.1

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

532

1.41

2.21

3.4

3.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

297

0.47

2.19

1.4

1.5

—

(3028300) Cannabinoids [Presence] in Urine

104

780

1.34

2.19

5.6

1.8

—

(3000034) Microalbumin [Mass/volume] in Urine

442

1.45

2.18

3.8

3.0

mg/l

169.6

35.4

1.20

334

(40758292) HTLV I+II Ab panel - Serum

2.30

2.14

1.3

1.5

—

(3027008) Opiates [Presence] in Urine

103

776

1.33

2.12

3.5

1.8

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

384

0.55

2.10

1.4

1.5

—

(3044007) Cell count panel - Peritoneal fluid

131

1.84

2.07

1.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

277

1.56

2.05

2.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

199

1.66

2.04

1.6

1.4

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.18

2.04

1.5

1.2

94.0

79.0

—

(3034426) Prothrombin time (PT)

125

1.84

2.02

1.2

—

(21494434) Karyotype in Bone marrow

425

1.44

2.01

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

351

1.49

2.01

1.5

1.6

—

(44806071)

2.50

2.01

1.2

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

385

1.46

1.98

2.0

1.7

mg/l

5.4

4.6

0.43

360

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

131

1031

1.28

1.98

1.1

u/ml

8.7

6.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

126

1.83

1.97

1.2

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

112

1.88

1.95

1.5

1.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

373

0.56

1.93

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

120

1.84

1.92

1.5

1.2

—

(4281824)

463

1.41

1.91

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

405

1.44

1.90

1.2

1.4

u/l

23.2

30.2

1.09

333

(3005033) Fetal Nuchal fold Thickness US

371

0.56

1.90

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.92

1.89

1.1

1.2

pmol/l

246.6

254.2

0.04

(3022689) Creatine [Moles/volume] in Urine

121

1.82

1.87

2.1

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

474

1.40

1.86

1.1

u/ml

6.7

3.7

0.42

225

(3000060) B lymphocytes [#/volume] in Blood

2.03

1.85

1.8

2.0

e6/l

830.0

1586.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.98

1.84

1.2

1.1

u/ml

0.3

1.7

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.17

1.82

1.0

—

(4034850)

185

1531

1.21

1.81

14.8

10.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

246

1.55

1.80

2.0

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

246

1.55

1.80

2.0

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.05

1.79

4.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

146

1.71

1.77

1.1

1.0

u/ml

1.0

0.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

863

0.73

1.76

1.3

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.44

1.75

1.1

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

185

1.62

1.74

1.3

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

289

1.49

1.73

1.3

1.6

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

147

1.70

1.73

1.3

1.6

mmol/l

9.4

8.2

0.57

(3008295) Osmolality of Serum or Plasma

473

1.38

1.72

1.3

1.4

mosm/kgh2o

281.0

275.8

0.79

352

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

290

1.49

1.71

1.3

1.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

398

1.41

1.70

1.8

1.7

u/ml

16.9

26.0

1.62

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

373

1.42

1.70

1.4

1.2

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.29

1.70

4.0

2.7

mg/l

2.7

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.29

1.70

1.0

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

1.88

1.70

1.2

1.3

mu/l

246.3

54.9

0.69

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

415

1.40

1.70

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

132

1064

1.25

1.68

2.7

2.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

459

1.38

1.67

1.1

u/ml

0.8

1.1

0.23

188

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.16

1.66

1.0

1.6

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.03

1.64

1.4

1.2

ng/l

204.8

1168.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.03

1.64

1.6

1.2

115.5

79.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.93

1.64

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

165

1.64

1.1

1.2

—

(3016038) Potassium [Moles/volume] in Urine

326

1.44

1.64

2.4

1.1

mmol/l

32.6

34.4

0.18

280

(21494815) CD4 cells/100 lymphocytes in Specimen

318

1.45

1.63

2.5

2.1

30.7

42.7

—

(3004616) Nuclear Ab [Presence] in Serum

521

1.35

1.63

1.3

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

449

0.64

1.59

1.3

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

198

1.57

1.59

4.8

5.2

u/ml

59.4

57.9

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

106

1.79

1.58

1.6

1.5

ug/l

0.3

0.4

0.68

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

448

0.65

1.57

1.3

1.4

—

(3027944) Amphetamines [Presence] in Urine

761

1.28

1.57

5.8

1.7

—

(4211845)

247

1.50

1.57

4.1

3.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

447

0.65

1.56

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

447

0.65

1.56

1.3

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

215

1.54

1.56

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

228

1955

1.17

1.55

2.6

3.7

u/ml

49.9

66.3

0.50

221

1884

(3038177) Helicobacter pylori Ab [Presence] in Serum

587

1.32

1.54

1.2

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

107

1.78

1.54

1.9

2.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

339

1.42

1.54

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.33

1.52

1.0

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.86

1.50

1.5

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.16

1.50

1.3

1.0

iu/ml

7.5

13.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

283

1.45

1.49

2.1

10.1

13.7

1.47

120

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

333

1.41

1.49

1.9

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.90

1.49

7.7

—

(44786800) Granulocytes/100 leukocytes in Body fluid

1.90

1.49

1.2

1.3

22.7

21.8

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

131

1.68

1.49

2.0

2.1

u/l

39.3

52.3

0.28

120

(3020650) Glucose [Presence] in Urine

101

1.78

1.48

1.4

1.5

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

402

1.37

1.46

1.1

—

30.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

236

1.49

1.43

2.2

2.6

42.3

36.5

0.65

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

413

0.65

1.43

1.8

1.5

—

(3002619) Bacteria identified in Specimen by Culture

1.82

1.41

1.6

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

263

1.45

1.38

1.2

1.3

u/ml

0.5

1.4

0.87

130

(3016018) Differential panel - Cerebral spinal fluid

407

1.35

1.37

1.1

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.20

1.36

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

473

4301

1.11

1.35

1.5

1.6

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

112

1.70

1.35

3.5

2.2

mmol/l

8.0

7.7

0.12

(40768800) Prostate Pathology biopsy report

1200

0.81

1.33

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.13

1.33

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

144

1206

1.20

1.33

2.0

1.8

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.74

1.30

2.6

2.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

209

1.49

1.29

1.2

1.1

ratio

1.1

1.0

—

(3000492) Spirometry study

423

3835

1.11

1.29

1.5

—

(3023410) Appearance of Cerebral spinal fluid

369

1.36

1.28

1.4

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

1.76

1.28

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

114

1.67

1.28

1.5

ug/l

8.2

9.2

0.38

114

(3029396) Erythrocyte agglutination [Presence] in Blood

2.08

1.27

1.1

2.9

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.00

1.27

1.5

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

370

1.35

1.27

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.29

1.26

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.40

1.24

1.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

733

1.24

1.9

pmol/l

190.0

199.1

0.40

685

(3047007) Chlamydophila sp Ab [Presence] in Serum

520

1.29

1.23

1.1

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

116

1.64

1.21

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.72

1.20

1.1

pmol/l

3.8

22.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.80

1.20

1.1

1.2

—

(3000012) Reticulocyte production index

297

1.38

1.19

1.3

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.75

1.18

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

298

1.38

1.17

1.6

1.9

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.70

1.17

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

463

1.30

1.17

1.5

1.4

e6/l

275771.3

84099.6

0.61

317

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

102

1.67

1.16

15.2

1.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

102

1.67

1.16

1.2

1.4

—

(3006462) Nitrate [Presence] in Urine

224

1.43

1.14

4.1

3.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

483

0.72

1.12

1.3

1.5

—

(3036603) Volume of Urine

301

1.36

1.12

1.7

1975.2

1812.8

0.21

(3005011) Chlamydia sp Ab [Titer] in Serum

1.90

1.12

1.8

1.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.90

1.12

2.5

2.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

151

1.52

1.11

1.1

u/ml

0.4

0.9

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

201

1.44

1.09

1.1

u/l

1.2

1.1

0.29

105

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.19

1.08

1.0

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.19

1.08

1.1

1.0

—

(3025315) Body weight

2.12

1.05

4.0

4.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.27

1.03

2.4

1.9

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.27

1.03

1.4

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.83

1.02

2.4

2.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

122

1.56

1.02

2.2

2.3

nmol/l

118.2

151.1

1.01

106

(3035320) C reactive protein [Mass/volume] in Body fluid

324

1.33

1.02

3.3

2.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

494

5327

0.92

1.01

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.89

1.01

1.6

1.4

umol/l

49.5

39.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.89

1.01

1.1

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

763

1.21

1.00

1.3

1.2

u/ml

47.0

38.8

0.18

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.65

1.00

1.3

—

(3028433) Virus identified in Specimen by Culture

147

1.50

1.00

1.4

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

121

1030

1.18

0.99

1.3

1.2

u/ml

2.4

7.1

2.22

154

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

129

1104

1.17

0.99

1.3

1.2

u/ml

11.8

43.9

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.17

0.98

1.0

1.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.95

0.97

1.0

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.80

0.96

3.7

5.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

100

1.60

0.96

7.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

255

2295

1.12

0.95

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.95

0.0

6.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.95

0.0

3.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.77

0.94

1.9

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

191

1.42

0.94

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

136

1568

0.86

0.94

1.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

158

1.46

0.93

1.3

1.2

g/l

40.9

39.4

0.24

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

123

1056

1.17

0.93

1.2

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

119

1020

1.17

0.92

1.3

1.2

u/ml

4.2

2.9

0.52

(3025018) Bordetella pertussis Ab [Titer] in Serum

192

1.41

0.92

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

499

1.24

0.91

1.1

1.2

mmol/l

7.4

7.6

0.08

355

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.63

0.90

2.0

1.2

—

(3006270) Folate [Moles/volume] in Blood

464

1.25

0.90

1.2

nmol/l

337.9

337.3

0.01

374

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

420

1.26

0.89

1.1

—

3.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1530

14761

1.05

0.89

4.5

4.6

22.9

22.2

0.97

797

7696

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

119

1.51

0.87

2.2

2.3

206.3

178.0

0.43

112

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.79

0.87

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.00

0.87

2.2

2.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.59

0.84

1.0

1.1

umol/24h

0.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.76

0.83

1.0

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

143

1255

1.14

0.83

1.4

1.3

iu/l

27.8

30.2

0.39

115

1068

(3037692) Legionella sp identified in Specimen by Organism specific culture

154

1.43

0.83

1.1

1.2

—

(3025130) Human papilloma virus identified in Specimen

411

0.75

0.83

1.8

1.7

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

266

1.32

0.82

1.2

1.1

mg/l

330.6

290.5

0.19

227

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

163

1.41

0.81

2.1

1.7

ug/l

52.1

54.3

0.07

158

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

249

1.33

0.81

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

138

1.45

0.81

1.1

miu/ml

1512.0

1592.3

0.11

138

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.70

0.80

1.0

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

848

1.17

0.80

1.2

u/ml

3.6

4.8

0.17

(1617658) Protocol used for examination of sentinel lymph nodes

329

0.73

0.80

1.0

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

252

2294

1.10

0.80

1.9

1.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

269

2457

1.10

0.80

1.1

1.2

iu/ml

138.7

136.3

0.03

895

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

122

1.48

0.79

1.3

48.4

29.9

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.79

0.0

1.3

—

3997.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

165

1.40

0.77

1.2

1.1

ng/l

205.7

544.3

0.86

(4094501)

103

1189

0.86

0.76

1.1

—

(4027681)

200

1.35

0.76

1.6

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.52

0.75

1.0

1.2

mmol/l

1.1

1.6

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.08

0.74

1.0

1.8

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.08

0.74

2.2

8.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

306

2825

1.09

0.73

2.3

2.4

au/ml

32.3

26.3

—

120

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.84

0.73

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

133

1.43

0.73

1.3

1.2

g/l

0.3

0.63

102

(3037556) Urate [Mass/volume] in Serum or Plasma

142

1.41

0.72

1.1

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.58

0.71

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

194

0.67

0.70

1.2

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.92

0.70

1.4

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

463

1.21

0.69

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

463

1.21

0.69

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1202

11604

1.04

0.69

1.6

mmol/l

1.5

1.3

11.50

996

9642

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.67

0.68

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.53

0.68

1.0

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

161

1.37

0.68

2.1

2.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

275

1.27

0.68

1.3

1.1

mg/l

45.9

41.6

0.14

221

(3045683) HLA typing for celiac disease panel - Blood or Tissue

205

1.32

0.67

1.1

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.79

0.66

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.79

0.66

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

250

1.28

0.65

1.2

1.1

nmol/l

0.1

12.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.61

0.65

1.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.72

0.64

1.0

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

234

1.28

0.62

1.1

1.6

u/l

5.4

7.3

1.21

194

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

138

1.38

0.62

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

433

1.20

0.62

1.1

u/ml

1.9

2.0

0.01

102

(3027035) Albumin [Mass/time] in 24 hour Urine

1.63

0.62

1.1

1.3

—

629.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.59

0.61

3.3

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1014

10500

0.96

0.61

3.0

3.2

ug/l

0.8

0.27

709

7346

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.57

0.60

1.1

1.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.57

0.60

1.3

1.5

—

(4212803)

1.57

0.60

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

105

1.43

0.60

1.0

1.1

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

0.00

0.59

0.0

1.5

—

0.6

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

0.00

0.59

0.0

1.5

—

1.0

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

0.00

0.59

0.0

1.5

—

0.7

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

0.00

0.59

0.0

1.5

—

1.6

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

0.00

0.59

0.0

1.5

—

2.1

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

0.00

0.59

0.0

1.5

—

1.3

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

0.00

0.59

0.0

1.5

—

0.7

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

0.00

0.59

0.0

1.5

—

2.9

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

0.00

0.59

0.0

1.5

—

3.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

131

1.37

0.59

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

0.00

0.58

0.0

1.5

—

1.9

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.71

0.57

1.0

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

211

1.28

0.56

1.1

iu/ml

7.8

11.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

239

1.26

0.55

7.6

6.5

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

168

1.31

0.54

1.0

1.1

u/ml

21.3

5.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.58

0.54

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

149

1357

1.10

0.53

2.1

1.8

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

250

1.24

0.52

2.2

2.1

ug/min

21.6

190.8

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

110

988

1.12

0.51

1.8

1.6

mu/l

318.6

301.5

0.20

899

(3023430) Cat dander IgE Ab [Units/volume] in Serum

342

1.20

0.51

1.0

1.1

u/ml

1.5

3.4

1.36

136

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.46

0.50

1.0

1.2

mmol/l

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

1.46

0.50

1.0

1.1

mmol/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

988

0.89

0.50

1.4

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

118

1.36

0.50

7.9

7.7

—

(3048879) Bone marrow aspiration report

145

1.31

0.48

2.1

1.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

108

0.65

0.48

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

446

1.17

0.48

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

1.52

0.48

1.1

1.2

—

(3024263) Appearance of Synovial fluid

272

1.21

0.47

1.8

1.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

365

0.82

0.47

1.6

1.7

—

(3051101) Glucose [Moles/volume] in Cord blood

1.38

0.45

6.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

138

1.31

0.45

1.9

2.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

272

2562

1.06

0.45

1.3

au/ml

47.3

54.5

—

112

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

112

1.34

0.44

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

338

3208

1.06

0.44

2.3

2.1

nmol/l

11.2

12.0

1.00

286

2788

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

321

1.18

0.43

1.3

1.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.61

0.43

1.0

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.61

0.43

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.61

0.43

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

113

1.33

0.42

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.43

0.42

1.1

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.56

0.42

1.4

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.52

0.41

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.41

0.0

9.7

—

(3008898) HLA-B27 [Presence]

120

1101

1.09

0.40

1.1

—

(3019174) dRVVT (LA screen)

1.47

0.40

1.0

1.2

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

24.4

—

(44813793)

241

1.20

0.40

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

106

0.66

0.39

1.9

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

207

1.21

0.36

1.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

208

1.20

0.35

1.0

1.2

—

(40768793) Breast Pathology biopsy report

929

0.91

0.34

1.4

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.33

0.33

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.30

0.33

3.5

2.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.30

0.33

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

100

1083

0.92

0.33

1.2

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

270

2578

1.05

0.32

2.0

1.9

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.30

0.31

2.8

3.6

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.29

0.29

1.2

1.1

—

184.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

157

1.21

0.29

1.3

1.2

ug/l

3.0

665.5

—

(3026470) Cobalt [Mass/volume] in Blood

344

1.13

0.29

1.9

ug/l

5.9

3.3

0.41

290

(3050129) First trimester maternal screen panel - Serum or Plasma

545

0.90

0.29

1.4

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

1.32

0.28

2.0

4.1

u/l

37.0

44.3

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.32

0.28

1.0

1.2

mmol/l

0.3

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

104

1.25

0.26

1.8

1.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.28

0.26

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

113

1061

1.07

0.26

2.1

1.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

132

1.21

0.25

1.1

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

106

1.23

0.23

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.28

0.23

1.2

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.28

0.23

1.2

1.9

—

(1002224) Polysomnography panel

146

1390

1.05

0.22

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.25

0.22

1.4

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

107

1.22

0.21

1.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.1

—

213.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

117

1.20

0.20

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.20

0.0

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.22

0.20

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

111

0.81

0.20

1.3

1.9

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.21

0.19

1.2

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.15

0.19

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

376

1.09

0.18

1.1

u/ml

4.8

2.4

0.37

141

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.21

0.18

1.3

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

166

1.14

0.18

1.3

1.1

—

(1761868) Lipid panel - Serum or Plasma

1374

13879

0.99

0.16

3.4

3.0

—

(3015183) Erythrocyte sedimentation rate

158

1.14

0.16

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.10

0.15

1.3

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

341

1.09

0.15

6.4

5.0

u/ml

382.6

85.8

0.37

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

328

0.91

0.15

1.0

ng/l

41.8

44.2

0.16

220

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

119

0.84

0.15

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

119

0.84

0.15

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

119

0.84

0.15

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

119

0.84

0.15

1.2

1.1

—

(3025577) Chromium [Mass/volume] in Blood

332

1.08

0.15

1.8

2.0

ug/l

2.9

2.1

0.24

272

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

333

1.08

0.14

1.3

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

326

0.92

0.14

1.0

ng/l

819.9

686.7

0.48

214

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

326

0.92

0.14

1.0

ng/l

353.5

331.2

0.24

222

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

258

2642

0.98

0.14

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

148

0.88

0.12

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

104

1.15

0.12

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.16

0.11

1.0

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

485

1.05

0.10

1.0

1.1

u/ml

3.6

2.7

0.33

201

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

329

1.06

0.10

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.14

0.10

2.2

4.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.11

0.09

1.0

1.1

umol/24h

1.4

1.7

—

(3001729) Color of Synovial fluid

1.04

0.09

3.8

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.83

0.08

1.2

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

236

0.93

0.08

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

421

1.05

0.07

1.4

nmol/l

0.5

0.3

0.66

325

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

225

0.93

0.07

1.2

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

108

1.11

0.07

1.1

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

285

1.05

0.06

1.3

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

102

0.88

0.06

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

1.11

0.05

1.6

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

960

1.02

0.05

2.0

1.7

iu/l

3.3

4.7

2.02

321

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

287

1.05

0.05

1.3

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

159

1.07

0.05

1.1

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

130

0.92

0.04

1.2

1.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

180

0.94

0.04

1.1

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

127

1253

1.01

0.03

2.0

1.6

mg/l

4.9

3.4

0.81

103

874

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

259

0.96

0.02

1.3

1.5

pmol/l

47.6

165.7

0.58

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

138

0.94

0.02

1.1

—

(40765096) Chromosome analysis panel by Banding

148

0.95

0.02

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

286

1.01

0.00

1.3

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

264

0.98

0.00

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

150

1.00

0.00

2.7

umol/l

28.1

29.9

—

111

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

179

1.01

0.00

1.7

1.6

nmol/l

2.3

6.3

0.97

153

(40759836) Histone Ab [Presence] in Serum by Immunoblot

285

1.02

0.00

1.3

1.1

—

(4133840)

1.04

0.00

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

287

1.01

0.00

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

287

1.01

0.00

1.3

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

2.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.94

0.00

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

2.8

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

0.00

0.0

2.2

—

0.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1755.0

—

(4038314)

0.00

0.0

1.3

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

39.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.7

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

1.2

—

(3000285) Sodium [Moles/volume] in Blood

0.96

0.00

1.6

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

124.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_CHOLECYST and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_CHOLECYST	1.555 [1.42, 1.71]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.098

During the follow-up period (1.1.1998 — 31.12.2019), 6483 out of 17162 females with K11_CHOLECYST died.

Males

Parameter	HR [95% CI]	p-value
K11_CHOLECYST	1.589 [1.43, 1.76]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 7076 out of 17274 males with K11_CHOLECYST died.

Mortality risk

Mortality risk for people of age

years, who have K11_CHOLECYST.

N-year risk	Females	Males
1	0.116%	0.234%
5	0.813%	1.706%
10	2.254%	4.341%
15	4.26%	8.344%
20	7.204%	13.939%

Relationships between endpoints

↥

Index endpoint: K11_CHOLECYST – Cholecystitis

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cholecystitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints